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ABSTRACT
CHARACTERIZATION OF TRANSFER OF THE MOBILE GENOMIC ISLAND
ENCODING METHICILLIN RESISTANCE AMONG STAPHYLOCOCCI
By Melissa Darlene Ray, Ph.D.
A dissertation submitted in partial fulfillment of the requirements for the degree of
Doctor of Philosophy at Virginia Commonwealth University
Virginia Commonwealth University, 2015
Director: Gordon L. Archer, MD
Senior Associate Dean for Research and Research Training
Professor, Departments of Internal Medicine and Microbiology and Immunology

The gene encoding methicillin resistance in Staphylococcus aureus (MRSA) is carried in
the chromosome on a large genomic island called SCCmec and is always inserted at the
att site within orfX. SCCmec has been designated a mobile genetic element but a
mechanism by which it moves among different strains and species of staphylococci has
never been demonstrated. This work shows that bacteriophage 80α is capable of
transducing SCCmec into a recipient cell, after which it can integrate into the bacterial
chromosome via homologous recombination. More importantly, this work characterizes a
conjugative mechanism of SCCmec transfer. Results demonstrate the capture of a 30.8
kb SCCmec element on a conjugative plasmid for the first time, its transfer into both S.
aureus and S. epidermidis recipients, and its excision from the plasmid with insertion in
the orfX att site in recipients. The element was integrated into the plasmid by
recombination between IS elements invariably present on all SCCmec types and
pGO1/pSK41-like conjugative plasmids. These data explain the movement of SCCmec
from reservoirs in commensal coagulase-negative staphylococci into different
Staphylococcus aureus lineages using a ubiquitous conjugative plasmid that can transfer
among staphylococci of different species and, thus, describes a mechanism for the
environmental dissemination of methicillin resistance in nature.

CHAPTER 1
Introduction

Staphylococci and Methicillin-Resistant Staphylococcus aureus
The genus Staphylococcus is comprised of more than forty different species of
Gram-positive bacteria, including the coagulase-negative staphylococci (CoNS) such as
Staphylococcus epidermidis and Staphylococcus haemolyticus and the coagulase-positive
staphylococci such as Staphylococcus pseudintermedius and Staphylococcus aureus. S.
aureus was first discovered from a surgical abscess in 1880 by Sir Alexander Ogston in
Scotland and has become the most researched member of the staphylococci because of its
ubiquitous role in disease (1). Staphylococci are a part of the normal flora, and the major
site of S. aureus colonization in humans and animals is the anterior nares. Individuals are
categorized as persistent carriers, intermittent carries, or noncarriers of S. aureus (2). The
bacterium spreads through skin-to-skin contact with an infected person and also by
contact with objects such as athletic equipment, towels, needles, and razors used by an
infected person.
S. aureus is an opportunistic pathogen, and infections can occur when the skin or
mucosal barriers have been breached. Infections range from minor, generally self-limiting
skin complications such as impetigo, furuncles, and boils to severe life-threatening
clinical manifestations, including but not limited to, bacteremia, osteomyelitis,
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pneumonia, necrotizing fasciitis, and endocarditis (3). S. aureus is the most common
cause of nosocomial infections and is also capable of causing a wide range of diseases
within the community (4). This organism causes severe diseases due to its ability to
express a plethora of virulence factors (3). Noteworthy virulence factors of most diseaseassociated strains include Panton-Valentine leukocidin (PVL), alpha-toxin, phenolsoluble modulins (PSMs), and superantigens. PVL is a bi-component exotoxin that is
able to form pores in the membranes of neutrophils, the first line of host defense against
infection, ultimately leading to their lysis (5, 6). Alpha-toxin is a pore-forming toxin
present in many S. aureus strains that does not lyse neutrophils but instead lyses other
immune cells such as macrophages and lymphocytes (7, 8). PSMs are a class of secreted
peptides that are able to recruit, activate, and lyse neutrophils (9, 10). Many strains of S.
aureus also produce superantigens that non-specifically activate T-cells, resulting in
massive cytokine release leading to serious toxinoses such as toxic shock syndrome (11,
12). In addition to a wide array of virulence factors, infections are further complicated by
the ability of S. aureus to develop resistance to multiple antimicrobial agents. The
increase of antibiotic resistant strains, especially methicillin-resistant S. aureus (MRSA),
has further complicated therapeutic approaches.
The first strain of MRSA was isolated in 1961 from a European hospital just two
years after the introduction of methicillin and soon after spread to other countries,
becoming a significant concern in the United States in the 1970s (13, 14). Currently, in
the United States MRSA, strains account for more than 50% of all S. aureus isolates
causing clinical disease (15).

Healthcare-associated MRSA (HA-MRSA) is mainly

associated with bacteremia and other invasive infections in hospitalized patients who
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often have other illnesses (3). MRSA infections account for prolonged hospital stays,
increased costs in the health care system, and the highest annual death rate for any
infectious species (16, 17).

Initially, MRSA strains were only problematic for

hospitalized patients and those with chronic illnesses, but in the 1990s MRSA became
more prevalent in the community - otherwise known as community-associated MRSA
(CA-MRSA). These strains usually cause skin and soft tissue infections (SSTIs) in
otherwise healthy people in the community, including children, professional athletes,
soldiers, incarcerated individuals, and parenteral drug users (18-21). Today CA-MRSA
strains, in particular USA300, are the frequent cause of bacterial infections in individuals
without health care exposure (3). These strains ultimately led to a rise of life-threatening
CA-MRSA infections such as community-acquired pneumonia (22).

During the past

two decades, MRSA and methicillin-resistant CoNS have spread throughout the world
(23). Treatment is difficult and cumbersome because MRSA strains are resistant to βlactam antibiotics.

Resistance to β-lactam antibiotics

Soon after the application of successful antibiotics to treat infectious diseases,
there was an immediate emergence of resistant bacteria. This increased resistance is due
to evolution and selective pressure of bacterial strategies to combat the actions of
antibiotics and is an aftereffect of the extensive use of antibiotics in medicine and
agriculture. Bacterial strategies to combat antibiotics include modifying and inactivating
the drug, eliminating the drug, and/or altering the target of the antibiotic. S. aureus has
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developed resistance to every major class of antibiotics, including aminoglycosides,
macrolides, tetracyclines, fluoroquinolones, oxazolidinones, mupirocin, glycopeptides,
and β-lactams (24).
Specifically, β-lactams are bactericidal, cell wall-active antibiotics that inhibit the
transpeptidation step of peptidoglycan synthesis. Both sensitive and resistant S. aureus
strains produce four transpeptidases, also known as penicillin-binding proteins (PBPs)
(25). β-lactams mimic the natural substrate of PBPs, which is the terminal D-alanine-Dalanine of the peptidoglycan, and covalently bind to and inhibit the activity of the PBPs
which prevents cross-linking of the cell wall resulting in cell death due to osmotic lysis
(26, 27).
Resistance to β-lactams in MRSA can be two-fold. β-lactams such as penicillin
are inactivated by β-lactamases, whereas β-lactamase-resistant antibiotics such as
methicillin, oxacillin, and nafacillin are ineffective because the bacterium produces an
altered target PBP. β-lactamases bind to and cleave the β-lactam rendering it inactive
(28). The gene encoding β-lactamase (blaZ) in S. aureus is usually located on a plasmid
and is regulated by two divergently transcribed genes, blaI and blaR1, encoding a
transcriptional repressor and a membrane spanning signal transducer, respectively (29,
30). In the presence of a β-lactam antibiotic, BlaR1 autocleaves and signals for the
cleavage of the BlaI repressor, resulting in derepression of blaZ transcription and
production of β-lactamase (31). To overcome enzymatic inactivation, β-lactamaseresistant antibiotics, such as methicillin, were introduced. However, methicillin resistant
strains quickly emerged due to the acquisition of the mecA gene (32, 33).
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mecA- an alternative penicillin binding protein (PBP2a)

The mecA gene encodes an alternate penicillin-binding protein (PBP2a) that has a
low affinity for β-lactam antibiotics. PBP2a is an inducible 76kDa high molecular weight
class B PBP (37). The penicillin-binding motifs are the same in the high affinity PBPs as
in PBP2a, so the structural basis for the low affinity of β-lactam antibiotic binding to
PBP2a is not well understood (38). Nonetheless, PBP2a substitutes for the necessary
functions of high-affinity PBPs that are blocked in the presence of β-lactam antibiotic so
that cell wall synthesis is able to occur at concentrations of antibiotic that would
otherwise be lethal.
Regulation of mecA is similar to that of blaZ, the staphylococcal β-lactamase. The
regulatory genes of mecA are mecI and mecR1, and they encode for a transcriptional
repressor and a membrane signal transducer, respectively, which are similar in structure
and function to blaI and blaR1 of blaZ, as mentioned previously (39-41). Specifically,
MecI binds to the promoter region of mecA and represses its transcription. Derepression
is achieved through MecI cleavage once the signal transducer, MecR1, has been activated
in the presence of a β-lactam such as methicillin (42, 43). Intact and fully functional mec
regulatory elements strongly repress PBP2a production (44, 45). Upon analysis, it was
found that the majority of clinical isolates, an example being the S. aureus strain COL,
have deletions in mecR1 resulting in constitutive PBP2a production (46-48).
Interestingly, both MecI and BlaI are able to bind to the promoter and repress
transcription of mecA (49). Therefore, in strains constitutively expressing mecA, if the
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plasmid-encoded β-lactamase and its regulatory genes are present then mecA transcription
and PBP2a production is co-regulated by the β-lactamase elements and expression is
controlled.
An important characteristic of methicillin resistance is the variation in its
phenotypic expression. MRSA strains that contain mecA and produce PBP2a can either
be heterotypically or homotypically resistant to β-lactam antibiotics, and the level of
resistance can vary according to culture conditions and the β-lactam used (27). The
majority of MRSA strains are heterotypically resistant to methicillin, meaning that nearly
all of the cells in heterotypic strains (99.9% or more) are susceptible to low
concentrations of β-lactam antibiotics (1-5µg/ml methicillin) with only a small population
of the cells (1 in 106) growing at methicillin concentrations of 50µg/ml or higher. This is
in contrast to the homotypic resistant phenotype where the entire population expresses
high level resistance and can grow at methicillin concentrations of 50-100µg/ml (50).
While the majority of MRSA strains are heterogeneous, there are clinical isolates, such as
S. aureus COL, and laboratory-derived mutants, that are homogeneous. In some cases it
is possible to select a homogeneous population from the heterogeneous population by
passage of the strain in the presence of a β-lactam. This conversion to homotypic
resistance is essentially due to selection of a highly resistant mutant population of cells
that, importantly, are also stable when passaged in antibiotic-free media (51). Overall,
heterogeneity and the other factors involved in this phenotypic characteristic of
methicillin resistance are important yet not fully understood.
Of recent importance, MRSA isolates were detected that were phenotypically
resistant to methicillin yet tested negative for mecA. This was first discovered in a bovine

	
  

6	
  

MRSA isolate, S. aureus LGA251, and upon further analysis a divergent mecA homolog
was identified (52). Since then, this homolog has been found in animal isolates from a
domestic dog, brown rats, a rabbit, sheep, and even in human mecA-negative MRSA
isolates from Scotland, England, and Denmark (52, 53). This homolog was eventually
named mecC and is 70% identical to S. aureus mecA (52). Harrison et al. have recently
reported a new allotype of mecC in Staphylococcus xylosus named mecC1 that shares
93.5% nucleotide identity to mecC in S. aureus LGA251 (54).

Regardless of the type,

the mec gene is always found in the same region of the staphylococcal chromosome and
is associated with approximately 30-50 kb of extra chromosomal deoxyribonucleic acid
(DNA) that is not found in susceptible strains. This region is known as staphylococcal
cassette chromosome mec or SCCmec.

Staphylococcal cassette chromosome mec, SCCmec

The SCCmec element carries the mecA gene, and, therefore, is found in all
MRSA. SCCmec elements are a unique class of staphylococcal mobile genetic elements,
and the emergence of different MRSA lineages is due to the acquisition and insertion of
the SCCmec element into the chromosome of susceptible strains. The first SCCmec
element was identified in the Japanese S. aureus strain N315. Soon after, two additional
SCCmec elements from different MRSA strains were discovered. Based on structural
analysis, these elements were classified as SCCmec types I, II, and III (55, 56). Shortly
after, many other types of SCCmec were discovered, such as types IV through XI, as well
as other variants of already reported SCCmec types ranging in size from 21 kb to 67 kb
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(57-65). One specific variant that has had tremendous epidemiological success is
SCCmec type IVa of USA300 CA-MRSA. This variant has the arginine catabolic mobile
element (ACME) located downstream of SCCmec, forming the SCCmec-ACME
composite island, and the presence of the arginine deiminase system encoded on ACME
enhances the ability of USA300 CA-MRSA to survive within the host and likely
contributing to its epidemiological success (66, 67).
With an increasing number of SCCmec variants, types, subtypes, and pseudoSCCmec elements described in the literature, the International Working Group on
Classification of Staphylococcal Cassette Chromosome elements (IWG-SCC) was
established in 2009 to define a uniform nomenclature system and establish guidelines for
identifying new SCCmec elements (68).

Different SCCmec elements share three

common features, as follows: i) a mec complex, consisting of the mec operon ii) a ccr
gene complex, composed of cassette chromosome recombinase (ccr) genes and iii)
joining (J) regions bordering the mec and ccr complexes (65, 68). SCCmec elements are
classified into types and subtypes based on the structural organization and genetic content
of these features. Types are defined by the combination of the type of ccr complex and
the class of mec gene complex. Subtypes are variations in the J regions with the same ccr
and mec gene complexes. SCCmec elements also frequently include integrated insertion
sequences, plasmids, and transposons that often encode additional resistance factors. The
molecular typing of MRSA is further characterized by pulsed-field gel electrophoresis
(PFGE), multilocus sequence typing (MLST), spa typing, and the designated SCCmec
type in order to define a MRSA clone as it relates to the genotype of the methicillinsensitive S. aureus (MSSA) strain in which it was integrated.
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Despite numerous differences in typing, all SCCmec elements have conserved and
defining features.

For instance, SCCmec elements always integrate into the

staphylococcal chromosome at a specific site designated attB within the 3’ end of the
orfX gene that encodes a ribosomal methyltransferase (69). The integrated element is
always flanked by direct and inverted repeat sequences (DR and IR respectively). All
elements also harbor the mec complex that consists of mecA, mecI, and mecR1 as well as
the ccr genes that encode serine recombinases that mediate site-specific integration and
excision of the element. In addition, SCCmec elements possess an extremely common
insertion sequence (IS), IS431, within its mec complex that is also frequently found on
many staphylococcal plasmids (64, 68). Based on these characteristics and the fact that
mecA is widely distributed among multiple staphylococcal species, SCCmec is
considered a mobile genetic element that can be transferred among staphylococci.

Excision of SCCmec

Excision is the first step in understanding how SCCmec is transferred among
staphylococci. Site-specific excision and integration of SCCmec is catalyzed by the Ccr
recombinases encoded within the element, which belong to the large serine family of sitespecific DNA recombinases named after the large C-terminal domain and the active-site
serine nucleophile (70, 71). This family includes many bacteriophage integrases, such as
those of phiC31, Bxb1, TP901-1, and R4 (72-77), as well as the transposases TndX and
TnpX from Tn5397 and Tn4451 (78, 79). The bacteriophage integrases usually mediate
integration reactions without the addition of other proteins, but the excision reaction
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requires an additional phage encoded directionality protein (74, 80-82). In contrast, the
large serine transposases TndX and TnpX catalyze both reactions without additional
factors (78, 79).

For SCCmec, the Ccr proteins alone, without the aid of other

staphylococcal proteins, are all that is required for the recombination reactions, and thus
they more closely resemble the large serine transposases TnpX or TndX.
SCCmec integration involves a fifteen base pair (bp) core attachment (att) site
referred to as attB, located within the 3’ end of orfX, which recombines with the similar
att site, attS, on the circular SCCmec element. As a result of the recombination reaction,
SCCmec integrates into the chromosome, with two direct repeats designated attR and attL
flanking the element on the left and right end respectively. Ccr recombinases also act on
attR and attL to excise the element. When SCCmec excises it forms a non-replicating
circular intermediate harboring the reconstituted attS site, and leaving the reconstituted
attB site within orfX on the chromosome. Jansen et al. discovered an additional att
sequence (attR2) within SCCmec located 84bp downstream of the previously identified
att sequence (attR1) at the 3’ end of orfX (83).
There are three phylogenetically distinct ccr genes: ccrA, ccrB, and ccrC. Certain
SCCmec elements have the ccrA and ccrB genes (ccrAB), contained within the same
transcriptional unit, whereas other elements, namely SCCmec type V, only have ccrC
(68). Secondary structural analysis revealed that CcrB contains a predicted DNA binding
motif and further biological analyses confirmed that CcrB binds directly to the core att
site sequence. While CcrA does not bind DNA, it was shown to interact with CcrB to aid
in excision and integration. Excision was shown to occur at both attR1 and attR2 sites
with both CcrA and CcrB, but CcrB alone could mediate excision at the internal attR2
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site without the help of CcrA (71). Both CcrA and CcrB are required for SCCmec
integration (84), and CcrC alone mediates excision and integration of SCCmec type V
(58). Several allotypes have been described for ccrA and ccrB and these are used to
classify the SCCmec types as mentioned previously. However, only one allotype was
found for the ccrC gene (68). Even though there is significant variation at the amino acid
level for the CcrA and CcrB proteins, CcrA and CcrB recombinases from each type can
excise the SCCmec of various types (85). In contrast, CcrC can only excise SCCmec type
V (58). The promiscuity of CcrA and CcrB proteins suggests that other mobile elements
with an att site sequence similar to SCCmec could potentially be inserted into the
staphylococcal chromosome at attL or attR via Ccr-mediated recombination. An example
is the SCCmec-ACME composite island mentioned previously which can excise via
CcrAB (66, 83). However, some specificity for Ccr-mediated excision and integration is
imposed by sequences flanking the att sites that differ among MRSA strains and are
important in the recognition, binding, and recombination mediated by CcrAB (86, 87).
It has been noted that there is a critical stoichiometry between CcrA and CcrB that
determines optimal activity for integration and excision, and that ccrAB overexpression
from a multicopy plasmid shifts the predominant recombination activity from integration
to excision resulting in conversion of MRSA into MSSA (71, 84, 85). On the other hand,
spontaneous excision of SCCmec has been observed on several occasions in vivo and in
vitro yet takes place at a low frequency (56, 88-91).

Stojanov et al. found the

spontaneous excision frequency of SCCmec to be 10-5 to 10-6 (166).
Spontaneous excision occurs at an extremely low frequency, and few studies have
investigated what regulates ccrAB expression. β-galactosidase assays and quantitative
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polymerase chain reaction (qPCR) studies have shown that β-lactams and vancomycin
increased ccrAB transcription in MRSA strains N315 and MW2 (92). Stojanov et al. also
sought to answer whether the ccrAB promoter region could carry specific operators for
alternative sigma factors, as recently shown in certain S. aureus prophages (93), but no
similar regions were found (94) Another hypthesis for ccrAB regulation was based on the
well-described regulatory excision system of conjugative islands of Bacillus subtilis, in
which the excisionase gene is regulated by a typical repressor and anti-repressor system
(95). Stojanov et al. searched for a related system in staphylococcal strains and, while
one was found in S. haemolyticus, none were found in S. aureus for ccrAB (94).
Therefore, ccrAB regulatory elements, if any, have yet to be identified.
In an important study, Stojanov et al. used promoter-green fluorescent protein
(GFP) fusions to measure the expression of ccrAB genes in individual cells of various
strains of MRSA carrying different types of SCCmec elements. They found that ccrAB
promoter activity was not present simultaneously in all the cells of a culture but only in a
small fraction of the entire population (94). This stochastic gene expression has been
referred to as “bistability” and has been described in the transfer of other genomic
islands.

Specifically, bistability in clonal bacterial populations is well known from

competence development and sporulation in B. subtilis (96, 97). Minoia et al. described
the role of bistability as it relates to horizontal gene transfer (HGT) for the first time with
the integrative and conjugative element (ICE), ICEclc, in Pseudomonas knackmussi (98,
99). In this scenario, cells seem to express phenotypic variation into transfer-proficient
and transfer-silent subpopulations, and results suggest that the bistable switch is
stochastic and can be further attuned by external conditions. The authors note that
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because excision is a requirement for ICEclc transfer, the stochastic decision for excision
forms a key event in transfer control. However, the low frequency of the bistable
population makes it a difficult mechanism to study (98). In contrast to ICEclc, the
activity of the ccrAB promoters tested by Stojanov et al. were influenced by determinants
elsewhere on the chromosome and not within the SCCmec element itself, as deletion of
the element did not alter promoter activity (94). In S. aureus, specifically, bistability
rates increased under various stressful environmental conditions such as high temperature
or treatment with a mutagen such as mitomycin C, and results showed that ccrAB activity
and bistability depended on the microbial background (94). The observations were
similar to the bistability of the ICEclc-related transfer, and optimal settings imply that
only a few cells in the MRSA population lose their advantageous SCCmec element to
become methicillin susceptible and thus sacrifice themselves in order to transfer SCCmec
into new recipient strains.

Horizontal gene transfer in S. aureus

Horizontal gene transfer is the exchange of DNA between two cells and is
important for bacterial evolution. Genomic islands (GEIs) are mobile DNA elements
able to undergo HGT by excision, transfer, and integration into a new cell. They are
grouped with other mobile DNA elements such as conjugative transposons and
integrative and conjugative elements (ICEs) (100-102). GEIs typically carry genes that
provide bacteria with advantageous characteristics such as virulence factors, antibiotic
resistance mechanisms, and toxin production to enhance bacterial adaptation and survival
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in otherwise adverse conditions (103-106). There are many well-described bacterial
GEIs, including SXT of Vibrio cholerae (105), ICEHin1056 of Haemophilus influenza
(106), staphylococcal pathogenicity islands (SaPIs) from S. aureus (103), ICEclc from
Pseudomonas knackmussi (99), PAPI-1 from Pseudomonas aeruginosa (107), and
Tn1546 from Enterococcus faecium (108). Based on similarities with these systems and
SCCmec characteristics discussed previously (i.e., presence of an antibiotic marker,
possessing serine recombinases for excision and integration, integration at a specific site
in the chromosome, presence of direct repeats at both ends of the element, and carriage of
IS431), SCCmec is considered a mobile element.
While SCCmec is believed to be a mobile element, the origins of mecA are still
unclear. What is known is that SCCmec elements are not restricted to S. aureus, and in
fact the identical SCCmec element is found in S. epidermidis RP62A as in S. aureus
N315. SCCmec elements are also commonly found in other staphylococci, such as S.
haemolyticus and S. pseudintermedius (109, 110). These observations and other data
suggest that CoNS may be the reservoir of SCCmec for S. aureus (34, 111).
Interestingly, a mecA homolog with 88% amino acid similarity to mecA in MRSA was
identified in Staphylococcus sciuri (112, 113). In addition, mecA homologs have also
been discovered in Macrococcus caseolyticus (114, 115) and in Staphylococcus fleuretti,
a commensal bacterium of animals (116, 117). Based on similarities of the mecA region
in these isolates and the discovery of mec allotypes in bovine MRSA isolates and other
animals, it has also been suggested that animals may act as a potential source of a mecA
precursor and for the emergence of new MRSA clones in human beings (53). However,
currently the origin of SCCmec is still unknown.
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It was formerly believed that the spread of MRSA was entirely due to clonal
expansion of a few successful strains, and thus suggesting that de novo acquisition of
SCCmec was quite rare. Kreiswirth et al. concluded that S. aureus had acquired mecA on
one occasion and that present MRSA clones were mere descendants of a prototypical
isolate (118). This conclusion is wrong, as more recent studies have indicated that the
horizontal transfer of SCCmec is more frequent than previously thought. For instance,
identical SCCmec elements are present in unrelated staphylococcal strains, and even in
different staphylococcal species, and different types of SCCmec elements are present in
closely related strains (119-121). Furthermore, the analyses of many epidemic MRSA
isolates from hospitals in different countries by molecular methods, including MLST and
DNA microarray analysis, reveal the existence of modern MRSA lineages that are
unrelated to the first MRSA isolate.

These findings demonstrate that the SCCmec

element has been horizontally transferred (120, 122, 123). DNA microarray analysis
from 36 MRSA isolates showed that the mecA gene was associated with five genetically
divergent groups of isolates, and thus has been horizontally transferred into distinct S.
aureus chromosomal backgrounds at least five times (122). MRSA clones have also
emerged from specific clonal complexes (CCs) on multiple occasions, resulting in
isolates with the same MLST type that differ in SCCmec type (120). Therefore, SCCmec
has been transferred to S. aureus on more than five occasions as some lineages have
acquired different SCCmec types, and recent studies have demonstrated that it has more
likely transferred about 15 times (120). In addition, with the emergence of CA-MRSA
strains, MLST and SCCmec typing data have shown that CA-MRSA isolates are related
distantly to HA-MRSA strains, demonstrating novel acquisitions of SCCmec (124).
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These data are evidence that MRSA isolates are not diversified descendants over the last
almost fifty years of an original MRSA clone, but rather that horizontal transfer of
SCCmec into different S. aureus lineages has played a significant role in the evolution of
MRSA.
Despite being transferred numerous times, some genetic backgrounds seem to be
better adapted than others to acquire SCCmec or mecA. Katayama et al. assessed the
effect of the recipient background on the methicillin resistance phenotype by introducing
plasmid-encoded mecA into various recipients (125).

Results demonstrated that

“experienced” hosts, or strains that previously had SCCmec and lost it, had a resistance
phenotype similar to that of the parental strain with SCCmec when plasmid-encoded
mecA was introduced. On the other hand, “naïve” hosts, or strains in which SCCmec had
never been introduced, selected against mecA expression. The authors also found that the
mecA regulatory genes, mecI and mecR1, as well as the homologous β-lactamase
regulatory genes, blaI and blaR1, helped permit the maintenance and expression of mecA
in “naïve” hosts. These data imply that there is a host barrier to SCCmec acquisition and
that some strains may be better adapted, compensated, or prepared for it, but the genetic
or biochemical basis for this observation is unknown.
The mechanism of horizontal transfer for SCCmec has yet to been determined.
There are three mechanisms of HGT in bacteria: transformation, transduction, and
conjugation. Because S. aureus is not naturally competent, transformation as a means of
transfer of SCCmec will be excluded. Transduction is the transfer of genetic from one
bacterium to another via a bacteriophage genetic vector. It was the first genetic exchange
mechanism discovered in staphylococci (126). Staphylococcal bacteriophages typically
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belong to serological groups A, B, and F, of which group B contains most of the known
transducing phages (127). Staphylococcal generalized transducing phages are of the P22
type, and Φ11 and 80α, which are temperate S. aureus phages, are the most studied (128130). Typically, transduction frequencies for plasmids range from 10-4 to 10-6, and for
chromosomal markers frequencies range from 10-6 to 10-8 (126).

Staphylococcal

transducing phages encapsidate genome-sized DNA fragments commensurate to the size
of the phage genome. Most of the widely used staphylococcal transducing phages have
40-50 kb size genomes. For plasmid transduction, those that are larger than the phage
genome are truncated while those that are smaller are packaged as linear multimers
during phage growth (131, 132).
One of the first pieces of evidence that phage could be environmental vectors for
the transfer of antibiotic resistance genes such as mecA was the detection of mecA in 71
phage DNA samples from pigs, poultry, and cattle fecal wastes (133-135). However, the
authors failed to characterize this finding any further in relation to SCCmec, and the
results were not surprising. Recently, Scham et al. showed that both bacteriophage 80α
and 29 were capable of transducing SCCmec type I and type IV to recipient strains of S.
aureus at low frequencies and also that this transduction required extended selection
times for mecA gene expression as well as the presence of a β-lactamase plasmid in the
recipient (136). The authors noted that there appeared to be a delicate balance between
insertion of SCCmec and mecA expression in recipient strains, and that the role of the βlactamase plasmid was to help regulate mecA expression as previously mentioned above
(125, 136). SCCmec types I and IV are the smallest of SCCmec elements (20-25 kb) and
thus may be easier to transduce via the phages used in this study, Φ11 and 29, which
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package 40-50 kb of DNA. This does not explain how the larger SCCmec elements may
be transferred. Equally important when considering transduction as a means for SCCmec
transfer, phages have historically been assumed to be highly species specific, with a
narrow host range (126, 137). This would imply that phage-mediated genetic exchange
would be highly restricted within a species, yet it is known that identical SCCmec
elements exist in S. epidermidis and S. aureus. Recently though, Chen and Novick have
reported that SaPIs have transferred via phage from S. aureus to Listeria monocytogenes
at the same high frequencies that they transfer in S. aureus (138). What is important to
note in this study, is that while these staphylococcal phages transduced L. monocytogenes
they failed to form plaques. This is important because the observed “silent” phagemediated transfer of DNA without infection that can only be assessed by gene transfer
potentially widens the host range of phages previously thought to be restricted. Other
studies have also described interspecies transfer among staphylococci mediated by phage
(176-179). These studies involve the SaPIs which transfer at a high frequency, and a
defined mechanism for the interspecies transduction has not been determined.
Bacterial conjugation has the broadest host range among the mechanisms for
HGT and has been shown to occur in both Gram-negative and Gram-positive bacteria and
also between the two groups (137, 139). It allows for the transfer of DNA from a donor
to a recipient through direct cell-to-cell contact (140). The study of Gram-negative
conjugative plasmids, such as F, RP4, and others, has significantly contributed to the
genetic and molecular understandings of bacterial conjugation. Specifically, plasmid
DNA transfers from donor to recipient as a linear, single strand via the help of two wellconserved elements: i) the origin of transfer, oriT, where DNA transfer initiates and
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terminates, and ii) a site-specific endonuclease that cleaves a single strand of DNA at the
nic site (141). The endonuclease proteins, relaxases, bind to the oriT region to form a
DNA-protein complex referred to as the relaxosome.

After relaxosome formation,

cleavage of a single strand of DNA occurs at the oriT site and DNA is transferred into the
recipient cell in the 5’ to 3’ direction via a specialized multiprotein complex named the
conjugation apparatus (141). The conjugation apparatus appears to be a subgroup of type
IV secretion systems that have evolved the capacity to translocate DNA (142). One of
the best-studied conjugative systems is the IncP transfer (tra) system of the Gramnegative conjugative plasmid, RP4 (143, 144). This system demonstrates the importance
of two protein complexes, the relaxosome, discussed above, and the mating-pair
formation (Mpf) complex (145). The Mpf complex, encoded by the conjugative plasmid,
is a multiprotein complex that is involved in trafficking the donor DNA into the recipient
cell. Eleven Mpf components (trbB to trbL and traF) are required for forming the IncP
pilus and conjugative junctions (144, 145).
Gram-positive conjugation systems have only recently been studied in the same
detail as those of Gram-negative bacteria. The obvious major difference between the two
systems is the machinery necessary to establish cell-to-cell contact.

Although no

structural studies have been performed on the Gram-positive conjugative apparatus, it can
be inferred that they would not require such sophisticated structures as pili to achieve
direct cell-to-cell contact, resulting in simpler tra functions.

Most staphylococci

conjugative plasmids range in the size of 40-60 kb, maintain low copy numbers, and
carry multiple resistance markers (126). While most conjugative plasmids to date in
streptococci and enterococci show broad host range, those found in staphylococci seem to
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be limited to the genus Staphylococcus (146, 147). Staphylococcal conjugative transfer
frequencies are usually in the range of 10-5 to 10-6 per donor cell and can depend on the
plasmid and the mating-pair genotype (126).
Conjugative plasmids in staphylococci were discovered in conjunction with the
emergence and spread of gentamicin resistance in U.S. hospitals in the mid-1970s (148,
149). Interspecies conjugative transfer was demonstrated by the presence of conjugative
plasmids with identical restriction patterns in S. aureus and S. epidermidis hospital
isolates from the same patient (148, 150, 151).

Two fully sequenced and well-

characterized prototypical conjugative plasmids from S. aureus are pSK41 (152, 153) and
pGO1 (154, 155, 165).

Plasmid pGO1 was the first Gram-positive staphylococcal

conjugative plasmid subjected to intense genetic analysis to understand its conjugation
functions and transfer. It is a 52 kb plasmid that transfers among staphylococci broadly
but is restricted to members of this genus. It also encodes resistance to gentamicin,
neomycin, trimethoprim and quaternary ammonium compounds (155). Genetic analysis
revealed two distinct regions on the plasmid necessary for conjugation: i) a 13.6 kb
conjugative transfer region (trs) consisting of fourteen open reading frames (ORFs), and
ii) a 2.2 kb region harboring the origin of transfer (oriT) and the gene encoding the oriT
nicking protein (Nes) (156). The pGO1 oriT is identical to sequences of oriT sites in
Gram-negative conjugative plasmids, and the trs genes are analogous to the tra functions
of Gram-negative plasmids as well.

The trs genes encode for a transmembrane

conjugative apparatus that the relaxosome (Nes-oriT complex) couples to and transfers a
single strand of pGO1 DNA from the donor into a recipient cell (154, 155). Small
nonconjugative plasmids that have a nicking site (mobS) and encode proteins necessary
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for nicking activity and relaxosome formation (MobA and MobB) can be mobilized by
pGO1 (157, 158).
Plasmid pGO1 also contains nine copies of IS431/IS257, and eight of these are
directly repeated which is important for plasmid evolution (159, 160, 165). Derivatives
of pGO1 were described after discovering plasmids encoding mupirocin resistance that
could be transferred among S. aureus recipients and were incompatible with pGO1 (161163) . Further DNA sequence analysis revealed that the mupirocin resistance gene had
integrated into pGO1 by recombination at IS elements and that this derivative also
subsequently lost genes encoding resistance to gentamicin, neomycin, and trimethoprim,
which were also flanked by IS elements. This pGO1 derivative is referred to as pGO400
and is 34 kb. Plasmid pGO400 and other derivatives appear following multiple transfers
and recombination at IS copies (164) . These derivatives demonstrate the importance of
IS elements for conjugative plasmid evolution and may serve as a model for the mobility
of other staphylococcal resistance genes.
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CHAPTER 2
Materials and Methods

Bacterial culture conditions. Bacterial strains used in these studies are listed in Table 1.
S. aureus and S. epidermidis strains were cultured in tryptic soy broth (TSB) or on tryptic
soy agar (TSA) (Difco, Lawrence, KS), and Escherichia coli cells were cultured in LuriaBertani (LB) broth or agar (Difco, Lawrence, KS). All bacteria were grown aerobically
and at 37°C unless otherwise stated. Broth cultures were grown shaking at 200 rpm with
a 1:5 liquid to air ratio. The antibiotics and concentrations, used when appropriate for
selection, were as follows: ampicillin (100 µg/ml), chloramphenicol (10 µg/ml),
tetracycline (10 µg/ml), erythromycin (10 µg/ml), kanamycin (20 or 100 µg/ml),
mupirocin (10 µg/ml), rifampin (10 µg/ml), and novobiocin (5 µg/ml) (Sigma-Aldrich, St.
Louis, MO).

Genomic DNA isolation. For isolating genomic DNA to be used as DNA templates in
polymerase chain reaction (PCR) assays, the QIAGEN DNeasy Blood and Tissue
Handbook Kit was used according to manufacturer’s instructions (QIAGEN, Valencia,
CA). For quick check of DNA in individual colonies for cloning screening purposes,
DNA was isolated from a single colony by resuspending a very small amount of the
colony in 20 µl of HPLC grade water (Mallinckrodt Baker, Pillipsburg, NJ) which was
then heated in the microwave for one minute exactly. One µl of the released DNA and
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ruptured cell mixture was used for PCR amplification. This form of isolated DNA cannot
be saved for long term and was discarded after use. To isolate high-quality DNA for
whole genome sequencing, the QIAamp DNA Blood Mini Kit was used following the
manufacturer’s protocol for the QIAGEN Maxi tip 500/G (QIAGEN, Valencia, CA). To
isolate DNA from phage virions (discussed in “Phage precipitation”), phenol-chloroform
extraction

was

performed.

An

equal

volume

of

a

25:24:1

mixture

of

phenol:chloroform:isoamyl alcohol (Sigma, St. Louis, MO) was added to the phage
virion sample, vortexed for 20 seconds, incubated at room temperature for 5 minutes,
then centrifuged at 13,000 rpm for 15 minutes at 4°C. The aqueous phase was carefully
transferred to a new tube, and 0.1 volume of 3M NaOAc pH 5.2 and 2 volumes of icecold 100% ethanol were added, mixed by inversion, and incubated overnight at -20°C.
The DNA was pelleted by centrifugation at 13,000 rpm for 30 minutes at 4°C and rinsed
by adding 1 ml of cold 70% ethanol and centrifuging for 10 minutes at 13,000 rpm and
4°C.

The ethanol was removed and the DNA pellet was allowed to air dry and

resuspended in 40 µl of HPLC grade water (Mallinckrodt Baker, Pillipsburg, NJ).

Plasmid DNA isolation. Plasmids used in these studies are listed in Table 1. Plasmids
were isolated from 3 ml of an overnight culture of E. coli or S. aureus using a QIAprep
Spin Miniprep kit (QIAGEN, Valencia, CA) as described by the manufacturer. When
plasmids were isolated from S. aureus, 1µg/ml lysostaphin (Sigma, St. Louis, MO) was
added to the lysis solution provided and incubated at 37°C for one hour. Then the
isolation procedure was continued according to the manufacturer’s protocol. Plasmids
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were analyzed by digesting with restriction enzymes (NEB, Ipswich, MA) and running on
agarose gels or sent for sequencing (Eurofins MWG Operon, Huntsville, AL).

Polymerase chain reaction (PCR). Polymerase chain reactions were performed in a
Bio-Rad PTC-0200 DNA Engine thermal cycler (Bio-Rad, Hercules, CA). Primers used
for PCR are listed in Table 2. Primers were ordered from Eurofins MWG Operon
(Huntsville, AL). 100 µM primer stock solutions were prepared in HPLC grade water
(Mallinckrodt Baker, Pillipsburg, NJ) and working stocks were diluted to 10 µM.
Endpoint PCR was performed using a TopTaq DNA polymerase kit (catalog number
200201) and following manufacturer’s instructions (QIAGEN, Valencia, CA).

Typical

PCR reaction conditions were as follows: one initial cycle at 95°C for 3 minutes followed
by 30 cycles of [94°C 30 seconds to denature, (Primer melting temperature in °C -5 )°C
30 seconds for hybridization, 70°C one minute per kb for extension] followed by a final
extension at 70°C for 10 minutes and then chilled to 12°C. PCR products were purified,
if necessary, using the QIAGEN PCR purification kit following manufacturer’s
instructions (QIAGEN, Valencia, CA) to be used for DNA mutagenesis or sent for
sequencing (Eurofins MWG Operon, Huntsville, AL).

Agarose gels. 1% agarose gels were prepared by dissolving agarose (Fisher Scientific,
Pittsburgh, PA) in 0.5X TBE (40 mM Tris-HCl pH 8.3, 45 mM boric acid, 1 mM EDTA)
at 100°C. Ethidium bromide was added to 0.1 µg/ml prior to pouring the gels. 5X
loading dye (50% glycerol, 0.25% bromophenol blue in TBE buffer) was added to the
DNA solution to a final dye concentration of 1X if a compatible dye was not already
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added in the PCR reaction. The DNA-dye mixture was loaded in agarose gels and
subjected to electrophoresis in 0.5X TBE running buffer at 120 volts until the dye front
had migrated roughly 75% the length of the gel. The gel was then visualized under UV
light (302-312 nm). The size of the DNA fragments was measured against either a 1 kb
ladder or a 100 bp ladder (NEB, Ipswich, MA). DNA fragments were purified, if
necessary, using the QIAGEN Gel Purification kit following manufacturer’s protocol
(QIAGEN, Valencia, CA) to be used for DNA mutagenesis or sent for sequencing
(Eurofins MWG Operon, Huntsville, AL).

Chromosomal DNA deletion mutant construction.

Chromosomal deletions were

performed by allelic replacement mutagenesis, using vector pKOR1 as discussed in the
“allelic exchange” section. This plasmid allows efficient cloning without the use of
restriction enzymes and ligase and instead relies on the phage lambda recombination
system. One kb fragments, one upstream and one downstream of the desired region to be
deleted, were amplified by PCR. A restriction enzyme recognition site was incorporated
at the 3’ end of the upstream 1 kb fragment and at the 5’ end of the downstream 1 kb
fragment by PCR. The 5’ end of the 1 kb upstream fragment contained an attB1 site
while the 3’ end of the 1 kb downstream fragment contained an attB2 site. PCR products
were digested with the appropriate restriction enzyme (NEB, Ipswich, MA) and ligated
overnight using T4 DNA ligase (NEB, Ipswich, MA). Two µl of the ligated product was
mixed with 1 µl of purified plasmid pKOR1 and 2 µl of BP clonase II enzyme
(Invitrogen, Carlsbad, CA) (for lambda recombination at attB sites on the insert and attP
sites on pKOR1) and incubated at room temperature for 5 hours, then introduced into E.
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coli TOP10 competent cells by transformation*. The resulting plasmid was isolated from
E. coli*, introduced into RN4220 by electroporation*, and transduced into the S. aureus
target strain* for allelic exchange*.
*discussed in other sections

Chromosomal DNA insertion mutant construction. Instead of relying on standard
techniques such as gene splicing by overlap extension, a new method was used to
construct gene insertion mutations in target strains without the introduction of extra
restriction sites. The In-Fusion HD Cloning Kit (Clontech, Mountain View, CA, catalog
number: 639648) was used following manufacturer’s instructions. This system allows for
directional cloning of one or more fragments of DNA into any vector. For allelic
exchange mechanisms to insert a desired gene in a S. aureus chromosome three
fragments of DNA were generated: 1) 1 kb of DNA immediately upstream of the desired
gene insertion site 2) the gene to be inserted 3) 1 kb of DNA immediately downstream of
the desired gene insertion site.

PCR primers were designed to introduce 15 bp 5’

extensions that were complementary to the ends of the adjoining fragment, and the outer
most fragments contained 15 bp 5’ extensions that were complementary to the ends of the
linearized vector (pUC18).

The In-Fusion cloning reaction was set up following

manufacturer’s instructions, and In-Fusion Enzyme fused the DNA fragments forming a
final circular plasmid construct containing combined insert of 1 kb of DNA upstream of
the desired gene insertion site-gene of interest to be inserted and 1 kb of DNA
downstream of the desired gene insertion site. Three µl of this fusion reaction were
transformed with E. coli TOP10 competent cells (Invitrogen, Carlsbad, CA). Following
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confirmation of the insert in pUC18 by restriction analysis, PCR, and sequencing,
primers were designed containing attB sites (for lambda recombination with pKOR1) to
amplify the insert by PCR for cloning into pKOR1 (as discussed in “Chromosomal DNA
deletion mutant construction”).

Site-directed mutagenesis. Single nucleotide polymorphisms (SNPs) were introduced
using site-directed mutagenesis. Briefly, the area of interest was amplified by PCR and
cloned into the pUC18 vector (2.7 kb) by restriction digestion followed by ligation.
“Around the Horn” mutagenesis was performed by designing overlapping forward and
reverse primers that contained the desired SNPs and then using the QuikChange
Lightning Site-Directed Mutagenesis kit (Agilent Technologies, Santa Clara, CA, catalog
number: 210219) following manufacturer’s protocol.

SNPs were confirmed by

sequencing (Eurofins MWG Operon, Huntsville, AL) the region on plasmid purified from
E. coli. Following confirmation of the mutations in the target region on pUC18, primers
were designed containing attB sites (for lambda recombination with pKOR1) and the
region of interest containing SNPs was amplified by PCR*, analyzed by gel
electrophoresis on 1% agarose gels*, and gel purified* for cloning into pKOR1
(discussed in “Chromosomal DNA deletion mutant construction”).
*discussed in other sections

Transformation of E. coli. Plasmid DNA (3 µl) of constructed plasmids discussed in
mutagenesis sections was added to 50µl of One Shot® TOP10 Chemically Competent E.
coli cells [F- mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 ΔlacX74 recA1 araD139
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Δ(araleu)7697 galU galK rpsL (StrR) endA1 nupG] (Invitrogen, Carlsbad, CA). The
mixture was incubated on ice for 30 minutes then immersed in a 42°C water bath for 45
seconds. One ml of SOC (2% tryptone, 0.5% yeast extract, 85.5 mM NaCl, 2.5 mM KCl,
10 mM MgCl2, 20 mM glucose) was added and the cells were allowed to recover by
incubating at 37°C with shaking at 200 rpm for one hour. Following recovery the cells
were plated on LB agar plates with appropriate antibiotic selection (usually ampicillin
100 µg/ml for most plasmids used when expressed in E. coli). The plates were incubated
overnight at 37°C and bacterial colonies were analyzed the following day.

Preparation of electrocompetent S. aureus cells. Electrocompetent S. aureus cells
were prepared from 50 ml of RN4220 grown in TSB to exponential phase (OD600nm =
0.6-0.8). All subsequent steps were on ice to keep the cells cold and each washing step
was followed by centrifugation at 4,000 rpm, 4°C, for 15 minutes. The cultures were
collected by centrifugation for 15 minutes at 4,000 rpm at 4°C. The pellet was washed
three times with 25 ml of ice-cold sterile water. The pellet was then washed one time in
25 ml of ice-cold sterile 10% glycerol. The pellet was then resuspended in 500 µl of icecold sterile 10% glycerol and incubated at room temperature for 15 minutes.
Resuspended cells were dispensed into 50 µl aliquots and stored at -80°C. Frozen
competent cells were discarded after six months.

Transformation of S. aureus. Plasmid DNA (5 ng-2 µg) isolated as discussed in the
“Plasmid isolation” section was added to 50 µl of electrocompetent S. aureus cells and
incubated on ice for 30 minutes. The mixture was then transferred to an electroporation
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cuvette with a gap length of 0.1 cm and pulsed one time using the Gene Pulser I (BioRad, Hercules, CA) set to the following conditions: 2.5 kV, 25 µF, and 100 Ω yielding a
field strength of 12.5 kV and a time constant of approximately 2.5 ms. Following
electroporation, 1 ml TSB (including a subinhibitory concentration of antibiotic when
necessary- 1:50 dilution of standard selection concentration) was added to the cells and
then transferred to a 15ml conical tube (Fisher Scientific, Pittsburgh, PA) and incubated
for 2 hours with shaking at 200 rpm at 37°C or at 30°C for the temperature-sensitive
plasmid pKOR1 used in allelic exchange. Aliquots of 100 µl were then spread on at least
three TSA plates supplemented with antibiotic for selection and grown overnight at 37°C
or 30°C, depending on permissive temperatures of the plasmid.

Phage Transduction. The generalized transducing bacteriophage 80α was used to move
plasmids from RN4220 into new recipient strains for allelic exchange discussed in the
“Allelic exchange” section or to move SCCmec from 450M into an isogenic recipient.
80α phage titers were determined as described in “Determination of phage titers” and
RN4220 containing the plasmid to be transduced or 450M was infected at a M.O.I. of 1.0.
4 ml TSA soft agar (TSB supplemented with 0.5 M CaCl2 and 0.4% BactoTM Agar
(Difco, Lawrence, KS)) was added to the phage and bacterial cell mixture and poured
over a TSA plate, which was then incubated overnight at 30°C. Five ml phage buffer (1
mM MgSO4, 4 mM CaCl2, 0.05 M Tris-HCl pH 7.8, 100 mM NaCl, 0.1% gelatin) was
added to the plate and the TSA soft agar was lightly homogenized. The mixture was
centrifuged at 4,000rpm for 15 minutes at 4°C and the supernatant was filter sterilized
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using a 0.45 µm pore-size filter (EMD Millipore, Darmstadt, Germany). The phage
lysate was stored at 4°C.
The 80α lysate containing the plasmid of interest was used to infect a recipient
strain at an M.O.I. of 1.0. 4ml TSB supplemented with 0.5M CaCl2 was added to the
mixture and the culture was incubated for 30 minutes at 30°C for infection. Following
infection, 5ml ice-cold 20mM sodium citrate was added the culture was and centrifuged
at 4,000 rpm for 15 minutes at 4°C. The pellet was washed twice with 2ml ice-cold
20mM sodium citrate and centrifuged at 4,000 rpm for 15 minutes at 4°C. Finally, the
pellet was resuspended in 1 ml TSB and serially diluted on TSA plates supplemented
with 5 mM sodium citrate and the appropriate antibiotic for selection.

Determination of phage titers. Phage titers were determined by plating serial dilutions
of a phage lysate on a sensitive S. aureus indicator strain (RN4220). A 100 µl aliquot of
each phage lysate dilution was added to 100 µl of a bacterial culture of RN4220, mixed
with 2 ml of TSA soft agar (TSB supplemented with 0.5 M CaCl2 and 0.4% BactoTM
Agar (Difco, Lawrence, KS). The mixture was poured onto a TSA plate and incubated
overnight at 30°C. Phage plaques were counted the next day to determine the phage titer
expressed as plaque forming units (PFU) per ml (PFU/ml).

Allelic exchange. The plasmid pKOR1 was used for allelic exchange because it has
positive selection for secondary recombination.

A colony of S. aureus containing

pKOR1 with the desired insert for allelic exchange (discussed in “Chromosomal DNA
mutant construction”) was grown at 30°C in TSB supplemented with chloramphenicol
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(10 µg/ml) overnight and then at 42°C the next day to inhibit replication of the
temperature-sensitive plasmid in order to favor integration of the plasmid via
recombination of the 1 kb homologous regions of DNA on the plasmid with homologous
regions on the chromosome. Cultures were then grown on TSA plates supplemented with
chloramphenicol (5 µg/ml) and large colonies were picked and cultured in TSB at 30°C at
the permissive temperature for plasmid replication to allow the plasmid to excise from
the chromosome via a second recombination event. The cultures were then plated on
TSA plates containing 200 ng/ml anhydrotetracycline (Clontech, Mountain View, CA).
Plasmid pKOR1 contains an antisense construct to the essential gene secY that is driven
by a tetracycline-inducible promoter. Any cells that still contain the integrated plasmid
and have not undergone secondary recombination will not grow after tetracycline
induction. Individual colonies that did grow following tetracycline induction were
streaked onto TSA and TSA plates supplemented with chloramphenicol (5 µg/ml) to
confirm sensitivity and loss of the plasmid. PCR analysis and sequencing (Eurofins
MWG Operon, Huntsville, AL) were performed to confirm that the target strains had the
desired mutations.

Phage precipitation. Phage lysates were filter sterilized using a 0.45 µm pore-size filter
(EMD Millipore, Darmstadt, Germany) to remove cellular debris. The sample was treated
with 2U DNAseI (NEB, Ipswich, MA) per ml of lysate at 37°C for 1 hour to remove any
bacterial extracellular DNA that may be present. The DNaseI was then inactivated by
incubating at 75°C for 10 minutes. Polyethylene glycol 8000 (PEG) and NaCl were
dissolved in the DNaseI-treated lysate to a final concentration of 0.1% and 5 M,
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respectively, and incubated overnight at 4°C. The next day, the lysate was centrifuged at
7,000 rpm 4°C for 20 minutes. The supernatant was decanted and the PEG phage
precipitate was resuspended in phage buffer (1 ml per 100 ml of original lysate). An
aliquot of supernatant was saved as the DNaseI treatment control. Encapsidated DNA
was isolated from the phage virions using phenol-chloroform extraction discussed in the
“genomic DNA isolation” section and was then subjected to PCR analysis.

Infective endocarditis rabbit model. All animal procedures were approved by the
Institutional Animal Care and Use Committee of Virginia Commonwealth University
(permit AM10030) under the supervision of Dr. Todd Kitten and were compliant with all
institutional policies and federal guidelines, including the USDA Animal Welfare Act
and the Public Health Service Policy on the Humane Care and Use of Laboratory
Animals.
New Zealand male white rabbits (2-3 kg) were purchased from RSI
Biotechnology and housed in the Virginia Commonwealth University animal suite for
one week prior to experimentation to allow the animals to acclimate and to monitor their
behavior under normal conditions. The rabbits were anesthetized and a 19-gauge catheter
(BD Bioscience, San Jose, CA) was inserted through the right internal carotid artery past
the aortic valve to cause minor damage. The catheter remained in the artery throughout
the experiment. Following surgery, the incision was closed with surgical clips. Animals
were monitored until fully recovered from the surgery and returned to normal activity.
Every 12 hours until the completion of the experiment rabbits received 0.03 mg/kg of
buprenorphine as analgesia. Two days following catheterization, 500 µl of S. aureus
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MR14 at 3.77x106 CFU/ml was inoculated into the bloodstream via introduction in the
peripheral ear vein. Three days post-infection, rabbits were euthanized by intravenous
injection of Euthasol (Virbac, Fort Worth, TX). Necropsy was performed and bacterial
vegetations were removed from the heart. The vegetations were then homogenized in 1X
phosphate buffered saline (PBS) (137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.47
mM KH2PO4), serially diluted, and plated on TSA and TSA supplemented with
tetracycline (10 µg/ml) and grown overnight at 37°C. The following day colonies were
counted to determine the number of CFU/g tissue.

Conjugative filter mating. Overnight TSB cultures of donor and recipient strains grown
in the presence of appropriate antibiotic selection were mixed in a 1:1 ratio (2 ml of
donor strain and 2 ml of recipient strain). The combined cells were centrifuged at 4,000
rpm, 4°C, for 15 minutes and washed once with 1X PBS (137 mM NaCl, 2.7 mM KCl,
4.3 mM Na2HPO4, 1.47 mM KH2PO4). The combined cell pellet was resuspended in 2
ml 1X PBS and forced through a sterile syringe onto a 25 mm diameter, 0.45 µm poresize nitrocellulose filter (EMD Millipore, Darmstadt, Germany). The filter was placed on
TSA agar in the absence of antibiotic pressure, bacteria side up, and was incubated at
37°︎C overnight. Cells were vortexed off of the filters in 1 ml of 1X PBS and were plated
on TSA containing appropriate antibiotics, selecting for donors, recipients, and
transconjugants (noted in Results and Table 1). Mating frequencies were expressed as
the number of transconjugants CFU/ml divided by the number of donors CFU/ml.
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Pulsed-field gel electrophoresis (PFGE). Bacterial strains subjected to PFGE analysis
were streaked on TSA plates supplemented with appropriate antibiotic(s) and grown
overnight at 37°C. Overnight cultures were then prepared from a single colony in TSB
supplemented with appropriate antibiotic(s) and grown at 37°C with shaking at 200 rpm.
Agarose plugs containing bacterial cells in suspension were then prepared. Aliquots 250
µl of the overnight cultures were centrifuged at 10,000 rpm for 5 minutes and the pellet
was washed in 1X PBS (137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.47 mM
KH2PO4) and then resuspended in 250 µl 1X PBS, followed by addition of 300µl of PIV
buffer (10 mM Tris-HCl pH 7.6, 1 M NaCl). Low melting agarose (Fisher Scientific,
Pittsburgh, PA; catalog number BP165-25) was dissolved in double-distilled water
(ddH2O) at 100°C to a final concentration of 2% and 300 µl of this was then added to the
cells and PIV buffer mixture and vortexed. Ten µl of a 1 mg/ml lysostaphin stock
(Sigma, St. Louis, MO) was added to the suspension and mixed by inverting the tubes
several times. Approximately 80 µl of the cells/agarose/lysostaphin mixture was added to
each slot in a plug mold, yielding six plugs per bacterial strain. The agarose plugs were
allowed to solidify at room temperature for 20 minutes. The six plugs for each strain
were combined in 5 ml of EC buffer (6 mM Tris-HCl pH 7.5, 1 M NaCl, 100 mM EDTA,
0.5% Brij-58, 0.2% sodium deoxycholate, 0.5% sarkosyl) in a 15 ml conical tube and
incubated at 37°C for 1-3 hours for bacterial cell lysis as monitored by visual clearing of
plugs. After lysis, the EC buffer was decanted and 5ml ESP buffer (0.5M EDTA, 1%
sarkosyl, pH 9.0) was added in addition to 5 µl of proteinase K (20mg/ml) (Life
Technologies, Grand Island, NY) and incubated in a 55°C water bath overnight. The
next day, the plugs were washed with gentle shaking at room temperature with many
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exchanges of ddH2O throughout the day, changing the water every 30 minutes. After
washing, the water was decanted and 5 ml 1X TE buffer (10 mM Tris-HCl pH 7.5, 1 mM
EDTA) was added. Plugs prepared in this way can be stored at 4°C for up to six months.
DNA in the plugs was digested by restriction enzymes NarI or SacI (NEB, Ipswich, MA),
where noted, in a 400 µl reaction volume with 120U restriction enzyme per plug. A 1%
agarose gel was prepared by dissolving SeaKem Gold Agarose (Lonza) in 0.5X TBE.
Plugs were loaded into the gel, along with a MidRange II PFG marker (NEB, Ipswich,
MA) and overlaid with 1% SeaKem Gold Agarose (Lonza) in 0.5X. The gel was placed
in a CHEF-DR III Pulse Field Electrophoresis System (Bio-Rad, Hercules, CA) and the
following settings were used for electrophoresis: 6 volts/cm, 1 second initial switching
time, 30 seconds final switching time, 22 hour run time, 14°C, 120° included angle).

Southern blot. Pulsed-field DNA gels were soaked for 10 minutes in 0.2 N HCl to
depurinate the DNA and then rinsed in ddH2O. Gels were then soaked in denaturation
solution (1.5 M NaCl, 0.5 N NaOH) for 45 minutes, rinsed with distilled water, and
soaked in neutralization solution (1 M Tris-HCl pH 7.4, 1.5 M NaCl) for 30 minutes, then
rinsed in ddH2O and soaked in fresh neutralization solution for 15 minutes. SSC buffer
solutions used below were prepared from a 20X SSC (3 M NaCl, 0.3 M sodium citrate,
pH 7.0) stock solution.

A positively charged nylon membrane (Roche, Mannheim,

Germany) and five pieces of Whatman 3MM paper were cut slightly larger than the gel.
The nylon membrane was submerged in distilled water, and once completely wet was
transferred to 2X SSC buffer. A reservoir tank was filled with 10X SSC, a glass plate was
used as a platform upon which a piece of Whatman 3MM paper was placed which was
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used to wick the 10X SSC solution through the transfer apparatus. The gel was placed
upon the Whatman 3MM paper and surrounded with parafilm. The nylon membrane was
placed on the gel followed by five pieces of Whatman 3MM soaked in 2X SSC. A 10cm
stack of paper towels, a glass plate and a weight of approximately 500g were layered on
top of the gel. The capillary transfer proceeded for 24 hours. After transfer, the nylon
membrane was allowed to dry at room temperature for at least 30 minutes. The DNA
was then fixed to the membrane by UV irradiation in a UV Stratalinker 2400 (Stratagene,
La Jolla, CA) at 120,000 µjoules/cm2. The membrane was either stored dry at 4°C or
subjected immediately to hybridization and detection.

Probe construction. Full-length mecA and mupirocin gene purified PCR products were
randomly primed and labeled with Digoxigenin-11-2’-deoxy-uridine-5’-triphosphate
(DIG-11-dUTP) using the DIG DNA Labeling and Detection Kit (Roche, Mannheim,
Germany, catalog number: 11093657910) following manufacturer’s protocol. Briefly,
10ng-3µg of purified DNA was denatured at 95°C for 10 minutes and quickly chilled on
ice.

Reaction conditions contained hexanucleotide mix for random priming, dNTP-

labeling mix including DIG-11-dUTP, and Klenow enzyme.

The reactions were

incubated overnight and then stopped by heating at 65°C for 10 minutes. Labeling
efficiency was determined following manufacturer’s instructions using included DIGlabeled control DNA.

Hybridization and detection. Nylon membranes were prehybridized in an appropriate
volume (20 ml/100 cm2 membrane) of DIG Easy Hyb buffer (Roche, Mannheim,
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Germany) at 42°C. The hybridization temperature (TH) was determined by TM - 20°C.
TM = 49.82 + 0.41(%GC) – (600/L) where L = length of DNA in bp. The mecA PCR
product was 2,007 bp with 30.64% GC and the mupirocin PCR product was 3,075 bp
with 28.75% GC. Primers used are listed in Table 2. Following prehybridization, 25
ng/ml DIG-labeled DNA probes were denatured at 95°C for 5 minutes and rapidly cooled
on ice. The denatured probes were added to an appropriate volume (3.5 ml/100 cm2
membrane) of pre-heated DIG Easy Hyb buffer (Roche, Mannheim, Germany) and mixed
well. The prehybridization solution was decanted from the membranes and the probeHyb buffer mixtures were added to the membranes and incubated overnight in tightly
sealed Tupperware containers with gentle agitation at 42°C. Following hybridization, the
membranes were washed twice at room temperature in low stringency wash solution (2X
SSC, 0.1% SDS) for 5 minutes each with shaking, and twice for 15 minutes at 42°C with
shaking in high stringency wash solution (0.5X SSC, 0.1% SDS). Next, immunological
detection was performed using the DIG DNA Labeling and Detection Kit (Roche,
Mannheim, Germany, catalog number: 11093657910) following manufacturer’s protocol
and using supplied reagents. DIG-labeled hybrids were detected with an anti-DIGalkaline phosphatase conjugate and visualized with the substrates NBT (nitroblue
tetrazolium salt) and BCIP (5-bromo-4-chloro-3-indolyl phosphate, toluidinium salt)
which produced a purple precipitate. Briefly using supplied reagents in the DIG Wash
and Block Buffer Set (Roche, Mannheim, Germany, catalog number: 11585762001),
membranes were rinsed for 2 minutes in washing buffer, incubated for 30 minutes in 100
ml blocking solution, incubated for 1 hour in 20 ml antibody solution, washed twice for
15 minutes each in 100 ml washing buffer, and equilibrated for 5 minutes in 20 ml
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detection buffer. The membrane was then incubated in 10ml freshly prepared color
substrate solution in the dark without shaking. When the desired spot intensities were
achieved the reaction was stopped by washing the membranes for 5 minutes in ddH2O
and results were documented by photography.
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Strains
E. coli TOP10

S. aureus NCTC 8325
S. aureus RN450
S. aureus RN4220
S. aureus 450M
S. aureus 450MEX
S. aureus MW2
S. aureus MW2EX
S. aureus N315
S. aureus N315EX
S. aureus MR4
S. aureus MR10
S. aureus MR14
S. aureus MR14EX
S. aureus Cowan I
S. aureus HT20020238
S. aureus MSSA476
S. aureus 18-1-2
S. epidermidis VCU113
S. epidermidis VCU129
pKOR1
pGO400
pWA46
pWA43
pCN36
pET30a
pUC19
pRM08
pRM11
pRM13
pRM19
pRM20
pRM21
pRM23
pRM24
	
  

Relevant characteristics
F- mcrA Δ(mrr-hsdRMS-mcrBC)
Φ80lacZΔM15 ΔlacX74 recA1 araD139
Δ(araleu)7697 galU galK rpsL (StrR)
endA1 nupG
MSSA; NRS077
NCTC8325 cured of ︎ Φ︎11, Φ︎12, and ︎ Φ︎13
Restriction-defective derivative of RN450
450 transformed with COL SCCmec type I
region DNA
MSSA; SCCmec excised from 450M
MRSA strain carrying SCCmec type IV
MSSA; SCCmec excised from MW2
MRSA strain carrying SCCmec type II
MSSA; SCCmec excised from N315
450M ΔmecA-ψIS1272::tetM
450MEX with orfX SNPs
N315 with modified SCCmec (ΔTn554
Δ15.4kb attL::tetM)
MSSA; SCCmec excised from MR14
MSSA; NRS104
MSSA; NRS242
MSSA clinical isolate
MSSA clinical isolate
MSSE clinical isolate
MSSE clinical isolate
Allelic replacement shuttle vector
pGO1 conjugative derivative
N315 ccrAB cloned downstream P-cadC in
pCN38
MW2 ccrAB cloned downstream P-cadC in
pCN38
pCN vector tetracycline resistance
E. coli cloning vector
E. coli cloning vector
pKOR1 Δ15.4kb insert
pET30a ΔmecA-ψIS1272::tetM
pKOR1 ΔmecA-ψIS1272::tetM
pUC19 orfX
pUC19 orfX SNPs
pKOR1 orfX SNPs
pKOR1 ΔTn554
pET30a attL::tetM
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Reference or
Source
Invitrogen

NARSA1
128
121
180
This work
181
This work
182
This work
This work
This work
This work
This work
NARSA1
NARSA1
183
90
184
184
185
164
71
71
186
Novagen
Invitrogen
This work
This work
This work
This work
This work
This work
This work
This work

pRM25
pRM27

pKOR1 attL::tetM
pGO400::MR14 SCCmec

This work
This work

Table 1. Bacterial strains and plasmids used in this study
1
The following strains were provided by the Network on Antimicrobial Resistance in
Staphylococcus aureus (NARSA) for distribution by BEI Resources, NIAID, NIH
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Primer
Name
MDR85
MDR86
MDR87
MDR88
MDR147
MDR148
MDR151
MDR152
MDR153
MDR154
MDR155
MDR156
MDR157
MDR158
MDR213
MDR214
MDR215
MDR216
	
  

Sequence 5’ to 3’

Target

GGGGACAAGTTTGTACAAA
AAAGCAGGCTAGGTGCCGA
AGCTCTG
CCGGAATTCTAGGGGTTCA
GTGCCTATCG
CCGGAATTCATCTGATAAG
GCTACGAACAG
GGGGACCACTTTGTACAAG
AAAGCTGGGTTGAGTCTCG
CAAATTGTCAG
TGGATAGACGTCATATGAA
GGTGTGC
TGGGTACAAGATGATACCT
TCGTTCCAC
TGCTCGAGTGCGGCCGCTG
GACCGAATGGACTAGCAC

Left flank for Δ15.4kb in J region
using pKOR1 (with attB1)
Left flank for Δ15.4kb in J region
using pKOR1 (with EcoRI)
Right flank for Δ15.4kb in J region
using pKOR1 (with EcoRI)
Right flank for Δ15.4kb in J region
using pKOR1 (with attB2)
mecA
mecA

Left flank for ΔmecAψIS1272::tetM; for pET30a cloning
using NotI and InFusion
GTAAGAGCATATTTGAGTG Left flank for ΔmecAAAGCAATCCGTAACGATG
ψIS1272::tetM; for pET30a cloning
G
using InFusion
CAAATATGCTCTTACGTGC TetM for ΔmecA-ψIS1272::tetM;
for pET30a cloning using InFusion
ACTTCGTACCATCCTAAATA TetM for ΔmecA-ψIS1272::tetM;
TTGAAGGCTAGTCAG
for pET30a cloning using InFusion
AGGATGGTACGAAGTTGC Right flank for ΔmecAACCACG
ψIS1272::tetM ; for pET30a cloning
using InFusion
GCTGATATCGGATCCACAC
Right flank forΔmecAAGAAGCCATATTTAGCGAT ψIS1272::tetM; for pET30a cloning
GATG
using BamHI and InFusion
GGGGACAAGTTTGTACAAA Insert from pRM11 for ΔmecAAAAGCAGGCTTGGACCGAA ψIS1272::tetM; has attB1 for
TGGACTAGCAC
pKOR1
GGGGACCACTTTGTACAAG
Insert from pRM11 for ΔmecAAAAGCTGGGTACACAGAAG ψIS1272::tetM; has attB2 for
CCATATTTAGCGATGATG
pKOR1
GGCCGGATCCTAGCGCATA orfX region for mutating SNPs in
GAGGAACTGTTAGTAG
450MEX; with BamHI for pUC19
GGCCGAATTCTTGAGTTCG orfX region for mutating SNPs in
GAAGATAAAGTTAATGCTC 450MEX; with EcoRI for pUC19
TGGAAGCAGGCCATAGCTG Around the horn on pRM19 to
AATATG
introduce 2 SNPs (bold) in orfX
CATATTCAGCTATGGCCTGC Around the horn on pRM19 to
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MDR221
MDR222
MDR285a
MDR286a
MDR287a
MDR288a
MDR289a
MDR290a
MDR291a
MDR292a
MDR311
MDR312
cR1
cR2
mR8
mL1
cL1
colA

	
  

TTCCA
GGGGACAAGTTTGTACAAA
AAAGCAGGCTTAGCGCATA
GAGGAACTGTTAGTAG
GGGGACCACTTTGTACAAG
AAAGCTGGGTTTGAGTTCG
GAAGATAAAGTTAATGCTC
TGCTCGAGTGCGGCCGCTG
AAAGCAAGACAATTAGTG
AGC
GATTTTCCTCCATTC
TTAGTTTTACTTATGATAC
GCC
GAATGGAGGAAAATCACA
TGAAAATTATTAATATTGG
CTCATACAGAATTTTACGAT
CTCCTCCTTTCCAC
AAAATTCTGTATGAGGAGA
TAATAATTTGG

introduce 2 SNPs in orfX
Mutated orfX insert from pRM20;
has attB1 for pKOR1
Mutated orfX insert pRM20; has
attB2 for pKOR1

Left flank for inserting tetM
downstream attL; InFusion cloning
into pET30a with NotI
Left flank for inserting tetM
downstream attL; InFusion cloning
into pET30a
tetM for inserting tetM downstream
attL; InFusion cloning into pET30a
tetM for inserting tetM downstream
attL; InFusion cloning into pET30a
Right flank for inserting tetM
downstream attL; InFusion cloning
into pET30a
GCTGATATCGGATCCAAGA
Right flank for inserting tetM
TTCTGAAGGTCTAACGTAA downstream attL; InFusion cloning
TC
into pET30a with BamHI
GGGGACAAGTTTGTACAAA Insert from pRM24 for inserting
AAAGCAGGCTTGAAAGCAA tetM downstream attL; using
GACAATTAGTGAGC
pKOR1with attB1
GGGGACCACTTTGTACAAG
Insert from pRM24 for inserting
AAAGCTGGGTAAGATTCTG tetM downstream attL; using
AAGGTCTAACGTAATC
pKOR1with attB1
TGAAACAGCAGCTAGAGT
Right SCCmec integrated junction;
GC
fwd
ATGTCCTGGCGTGTCTATG Right SCCmec integrated junction;
ATG
rev
AAGAATTGAACCAACGCAT Left SCCmec integrated junction;
GA
fwd
AAACGACATGAAAATCACC Left SCCmec integrated junction;
AT
fwd
ATGAAAGACTGCGGAGGC Left SCCmec integrated junction;
TAACT
rev
GAATCTTCAGCATGTGATT Right SCCmec integrated junction;
TA
fwd
ATTTAATGTCCACCATTTA Right SCCmec integrated junction;
ACA
rev
GTTCCCAGTAGCAACCTTC Left SCCmec integrated junction;
C
rev
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colB
8325_
0042F
8325_
0042R
ermAfwd
ermArev
MupProbe
Fwd
MupProbe
Rev
MecProbe
Fwd
MecProbe
Rev

CAATGAAAGCTTGGAAGA
AGGGC
TGCGATTGTTAATGGGATA
GG
TGCACATAATCCTCCAATG
C
TGATGGAGGCTTATGTCAA
GTG
TTCAAAGCCTGTCGGAATT
G
TCCTCATGCTGGCCATGTT
C
AACGCAGTCATTATCTTCA
CTGAGTTG
TGGCCAATACAGGAACAG
C
TGGCATTGTAGCTAGCCAT
TCC

Table 2. Primers used in this study
Sequence in bold = annealing sequence
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Right SCCmec integrated junction;
fwd
ORF0042
ORF0042
ermA
ermA
mupirocin resistance gene
mupirocin resistance gene
mecA
mecA

CHAPTER 3
Results:
Excision of SCCmec

As previously mentioned, site-specific excision and integration of SCCmec is
catalyzed by the Ccr recombinases, CcrA and CcrB, encoded within the element (70, 71),
and the recombinases from one SCCmec type can act on and excise other SCCmec types
(85). Also mentioned, ccrAB overexpression from a multicopy plasmid results in high
frequency excision (84, 85). The plasmid pWA46 used in these studies expressed ccrAB
gene complex type II under the control of a cadmium-inducible promoter so that in the
presence of inducer (cadmium) ccrAB was overexpressed, and resulting in high frequency
excision. In the absence of a plasmid driving excision, ccrAB is expressed from its own
SCCmec element and results in very low spontaneous excision frequencies (10-5 to 10-6)
(166). Therefore, SCCmec excision is either referred to as induced or spontaneous.
Characterizing excision is the first step in understanding how SCCmec is transferred
among staphylococci.
Inducible excision frequencies were determined over three days for S. aureus
N315 SCCmec type II and 450M SCCmec type I using pWA46 in the presence and
absence of cadmium induction. SCCmec elements also frequently harbor plasmids and
transposons that often encode additional resistance factors; these resistance markers were
used for excision screening purposes. Specifically, plasmid pUB110 is integrated in
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N315 SCCmec type II and includes a gene that encodes kanamycin resistance. SCCmec
type I in 450M was genetically manipulated to carry an internal tetracycline marker
(tetM) to generate strain MR4. Over three days, ccrAB-mediated inducible excision was
monitored in the presence and absence of cadmium induction by screening for loss of the
resistance phenotype. Each culture of S. aureus N315 or S. aureus MR4 started from a
single colony grown in TSB with or without cadmium chloride (5 µM), and a 1:1000
dilution was done using the same conditions for the following day up to three days. Each
day, serial dilutions of the bacterial cultures were prepared and plated on TSA plates with
or without cadmium chloride (5 µM), and the next day over 100 individual colonies from
each strain grown in both the presence and absence of cadmium induction were plated to
either TSA plates with kanamycin (20 µg/ml) or tetracycline (10 µg/ml) to screen for loss
of resistance. Figure 1 shows the results of S. aureus N315 SCCmec type II inducible
excision, and Figure 2 shows the results of S. aureus MR4 SCCmec type I inducible
excision.

After three days, inducible excision of S. aureus N315 SCCmec type II was

88.5% (88.5% of colonies screened were kanamycin sensitive) whereas S. aureus MR4
SCCmec type I inducible excision was 29.0%.
In these experiments, as stated above, ccr gene complex type II was
overexpressed to induce SCCmec excision. Even though CcrAB from one SCCmec type
can act on and excise other SCCmec types (85), differences among types may account for
variable excision frequencies. This could potentially explain why inducible excision for
SCCmec type I was only 29.0% after three days following induction with a type II ccr
gene complex.
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Figure 1. S. aureus N315 pWA46 SCCmec Type II Inducible Excision
N315 SCCmec type II contains a gene that encodes kanamycin resistance. pWA46
expresses ccrAB under the control of a cadmium-inducible promoter. Excision was
monitored by screening for loss of kanamycin resistance for three days in the presence or
absence of cadmium induction (5 µM cadmium chloride). At day 3, inducible excision of
N315 SCCmec was 88.5% (88.5% of colonies screened were kanamycin sensitive) and in
the absence of cadmium induction excision was 4%.
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Figure 2. S. aureus MR4 pWA46 SCCmec Type I Inducible Excision
MR4 SCCmec type I carries a gene that encodes tetracycline resistance. pWA46
expresses ccrAB under the control of a cadmium-inducible promoter. Excision was
monitored by screening for loss of tetracycline resistance for three days in the presence or
absence of cadmium induction (5 µM cadmium chloride). At day 3, inducible excision of
MR4 SCCmec was 29.0% (29.0% of colonies screened were tetracycline sensitive) and in
the absence of cadmium induction excision was not detected.
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In addition, data from Figures 1 and 2 also show that in the absence of inducer,
SCCmec excision frequencies were low or not observed: 4% by day three for N315 and
0% for MR4. As previously mentioned, spontaneous SCCmec excision frequencies are
10-5 to 10-6 (166). The 4% excision frequency detected for N315 in the absence of
inducer could be attributed to the fact that the cadmium-inducible promoter is not tightly
regulated, and so ccrAB is likely being expressed more than expected.
To provide a tool for monitoring excision without relying on negative phenotype
(the absence of resistance) screening techniques for such a low frequency event, a strain
was created that allowed positive selection for excision (MR14) (Figure 3). To positively
select for excision in S. aureus N315 SCCmec type II, a promoterless gene encoding
tetracycline resistance (tetM) was inserted immediately downstream of SCCmec attL.
When SCCmec is excised, tetM expression would be driven by the orfX promoter. In
addition, it was necessary to remove 15.4kb of DNA in the SCCmec J region immediately
5’ to the promoterless tetM gene because promoter activity in this region was generating
tetracycline resistance in the absence of SCCmec excision. This reduced the total size of
the SCCmec element in MR14 from 53kb in the intact N315 SCCmec element to 30.8kb.
Transposon Tn554 was also deleted, which was important when investigating intact
SCCmec transfer via transduction and conjugation (discussed in subsequent chapters) to
avoid transposable mechanisms of gene transfer.
After the creation of MR14, it was important to make sure SCCmec excised at a
similar frequency to intact N315 SCCmec. To test this, pWA46 was introduced into
MR14 and a single colony was grown overnight in the presence and absence of cadmium
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Figure 3. The creation of MR14 for positive selection for excision
S. aureus N315 SCCmec (53 kb) was modified to allow positive selection for excision.
The resulting strain is MR14. A promoterless gene encoding tetracycline resistance
(tetM) was cloned immediately downstream of SCCmec attL. 15.4kb of DNA upstream
of tetM was deleted to remove promoter activity in this region that was generating
tetracycline resistance in the absence of excision. The Tn554 region (6.7 kb) was also
deleted. The resulting size of MR14 is 30.8 kb. Cells with integrated SCCmec are
tetracycline sensitive and kanamycin resistant. Excised cells (MR14EX) express tetM
from the orfX promoter and are tetracycline resistant and kanamycin sensitive.
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induction. The resulting cultures were plated on TSA and TSA with tetracycline (10
µg/ml) and colonies were counted the next day. Tetracycline resistant colonies were also
plated on TSA kanamycin (20 µg/ml) to confirm sensitivity and thus excision. After one
day, in the presence of cadmium induction, 7.0x107 CFU/ml were tetracycline resistant
and total cell growth on TSA was 2.5x108 CFU/ml, or in other words 28.0% (TET/TSA x
100) of the total population had excised SCCmec. In the absence of cadmium induction,
8.0x106 CFU/ml were tetracycline resistant and total cell growth on TSA was 4.0x108
CFU/ml meaning that 2.0% of the total population excised SCCmec in the absence of
cadmium induction. Figure 4 expresses the data as a percentage of tetracycline growth
relative to growth on TSA (total population) in order to show that MR14 inducible
excision at day one (28.0%) determined by positive selection is comparable to excision
results determined by screening for loss of SCCmec as shown in Figure 1, which was
20.5% at day one.
MR14 was also used to determine the frequency of spontaneous excision by
plating serial dilutions of an overnight culture on TSA and TSA with tetracycline
(10µg/ml). Figure 5 shows the total bacterial counts, and the frequency of spontaneous
excision (excised population/total population) is 1.16x10-6. It was hypothesized that
spontaneous excision frequencies during infection may be greater than 10-6 since ccrAB
expression had been reported to increase under stressful conditions (92) and transfer of
SCCmec has been observed during colonization and infection on multiple occasions (8991). Therefore, MR14 spontaneous excision was also determined using a rabbit infective
endocarditis model (see Materials and Methods). Eight rabbits total had an average of
4.92x108 CFU/g tissue, and an average of 3.32x102 CFU/g tissue grew in the presence of
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Figure 4. S. aureus MR14 pWA46 Inducible Excision at Day 1	
  
MR14 SCCmec inducible excision was monitored by positive selection on tetracycline.
pWA46 expresses ccrAB under the control of a cadmium-inducible promoter. In the
presence or absence of cadmium induction (5µM cadmium chloride), excision
percentages were determined by plating overnight cultures on TSA and TSA with
tetracycline. and comparing growth on tetracycline to total growth without antibiotic
selection. MR14 SCCmec inducible excision at day one was 28.0% and in the absence of
inducer was 2.0%.
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Figure 5. S. aureus MR14 Spontaneous Excision
MR14 spontaneous excision in vitro was determined by plating serial dilutions of an
overnight culture on TSA and TSA with tetracycline. An average of 4.93x108 CFU/ml
grew on TSA representing the total population. An average of 5.70x102 CFU/ml grew on
TSA with tetracycline representing the excised population. The frequency of spontaneous
excision (excised population/total population) was calculated to be 1.16x10-6.
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tetracycline (Figure 6). The frequency of spontaneous excision was determined to be
5.02x10-7 (excised population/total population) and was, thus, similar to the spontaneous
excision rate measured under laboratory culture conditions.
As previously mentioned, when SCCmec is integrated in the chromosome attR
and attL flank the element on the left and right end, respectively. When SCCmec excises
it forms a non-replicating circular intermediate harboring the reconstituted attS site and
leaves the reconstituted attB site within orfX on the chromosome (70, 71). Using the
differences in sequences across these four att-site junctions, a polymerase chain reaction
(PCR) based approach could also be used to monitor excision and integration of SCCmec
as wells as the presence of the excised SCCmec circular element (Figure 7). Figure 8
shows that a typical MR14 bacterial culture undergoing spontaneous excision has a
mixed population of integrated, excised, and circular SCCmec products, thus
demonstrating the dynamic process of excision and integration within a population. On
the other hand, a completely excised population, designated as MR14EX, only had the
excised chromosomal junction, and, importantly, the circular non-replicating SCCmec
intermediate had been lost.
Results in this chapter differentiate between induced and spontaneous excision by
the drastic difference in excision frequencies. Based on the observation that SCCmec
type II in combination with overexpression of its paired ccr gene complex type II led to
the highest inducible excision frequency, this combination was chosen for further studies
to induce SCCmec excision when attempting to mobilize SCCmec. The construction of a
positive selection strain (MR14) for spontaneous excision aids in monitoring excision
that would otherwise rely on screening for an event that has a low frequency of 10-6. This
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Figure 6. MR14 spontaneous excision using a rabbit infective endocarditis model
MR14 spontaneous excision was also determined using a rabbit infective endocarditis
model. Eight rabbits total had an average of 4.92x108 CFU/g tissue in their heart
vegetations. Where an average of 3.32x102 CFU/g tissue grew in the presence of
tetracycline. Excision was not detected in four of the rabbits. The frequency of
spontaneous excision was determined to be 5.02x10-7 (excised population/total
population).
This graph was made using GraphPad Prism 6.
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Figure 7. Diagram of PCR based approach to determine excision and integration of
SCCmec
A combination of four primers designed for each strain were used to amplify products by
PCR to determine the presence of integrated, excised, and circular SCCmec. Primers used
for each strain are included in the primer list in Table 2.
Integration of SCCmec1. Left integrated chromosomal junction amplified using a forward primer upstream of
attR (maroon) and a reverse primer downstream of attR internal to SCCmec (green).
2. Right integrated chromosomal junction amplified using a forward primer internal to
SCCmec upstream of attL (green) and a reverse primer downstream of attL (maroon).
Excision of SCCmec3. Excised chromosomal junction amplified by the forward primer upstream of attR
(maroon) and the reverse primer downstream of attL (maroon).
4. Circular SCCmec junction amplified by the primers internal to SCCmec (green) would
be able to amplify the excised circular SCCmec junction following excision and
circularization of SCCmec.
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Figure 8. Amplification of SCCmec integrated and excised junctions in MR14 and
MR14EX
Lane A. NEB 1 kb ladder; Lane B. NEB 100 bp ladder; Lane 1. Left integrated
chromosomal junction (primers: cR1/mR8); Lane 2. Right integrated chromosomal
junction (primers: MDR311/MDR312); Lane 3. Excised chromosomal junction (primers:
cR1/MDR312); Lane 4. Circular SCCmec junction (primers: mR8/MDR311)
In the first panel, DNA from a MR14 bacterial culture has a mixed population of
integrated, excised, and circular SCCmec products. Shown in the middle panel, a
completely excised population, designated as MR14EX, only had the excised
chromosomal junction, and the circular SCCmec following excision had been lost.
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model confirmed that the spontaneous excision frequency of SCCmec is 10-6 by simply
selecting for cells that grow in the presence of tetracycline. The consistent low frequency
of spontaneous excision that is seen both laboratory culture and in a rabbit infective
endocarditis model likely correlates to the bistability phenotype described previously (94)
and, although low, is assumed to be advantageous for the overall population because only
a few cells in the MRSA population lose their SCCmec element to become methicillin
susceptible and thus sacrifice themselves in order to transfer SCCmec into new recipient
strains. It is also important to note that although integration and excision are dynamic
within the entire population, an excised (EX) cell will lose all integrated SCCmec as well
as the circular SCCmec intermediate, as shown by PCR results. This has significant
implications when investigating transfer of the element because the circular intermediate
would require a mechanism of capture and transfer before it is lost completely.
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CHAPTER 4
Results:
SCCmec mobilization via bacteriophage

Transduction of SCCmec was the first mechanism of transfer tested. Based on the
previously mentioned data that mecA was found in a variety of environmental phage
isolate samples (133-135), and the abundance of bacteriophage in the environment,
transduction was deemed a probable mechanism of SCCmec transfer. Collaboration with
undergraduate students from James Madison University also found mecA gene products
by PCR from various phage samples isolated from different environmental sources in
Harrisonburg, Virginia (data not shown).

Additional attempts to characterize the

presence of mecA and SCCmec in these phages were not successful, but results were
compelling enough to test the possibility of SCCmec transduction in vitro.
To assess the ability of phage to transduce SCCmec, an optimized donor strain
was first constructed.

The first consideration was the size of SCCmec since, as

mentioned previously, transducing phage encapsidate DNA commensurate to the size of
the phage genome (131, 132), and staphylococcal bacteriophage 80α used here has a
genome size of 43.9 kb. While N315 SCCmec type II would have been ideal due to its
high frequency excision, it is also one of the largest SCCmec elements (53 kb) and would
not be able to be packaged fully intact by bacteriophage 80α.

Furthermore, N315

contains prophages that interfered with bacteriophage 80α infection, so N315 was not
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considered an ideal donor. Therefore, strains with SCCmec type I (34.3 kb) and SCCmec
type IV (24.1 kb) were next considered as donor candidates based on their small sizes.
The next consideration was the ability of bacteriophage 80α to infect and produce
high phage titers from the donor strain to maximize the number of phage particles
produced and thus the probability of encapsidated SCCmec. 80α phage lysates were
prepared from strains MW2 (SCCmec type IV), COL (SCCmec type I), 450M (SCCmec
type I), and RN4220 as a control and titers were determined by plating on an indicator
strain (RN4220). Results in Figure 9 show that 450M (SCCmec type I) produced the
largest phage titer, 1011 PFU/ml, so it was chosen as the donor strain in SCCmec
transduction experiments. SCCmec type IV was ruled out as a transduction candidate
because the strain harboring this type, MW2, was determined to have prophages that
interfered with bacteriophage 80α resulting in a low phage titer.
In order to select for transfer of SCCmec into a recipient strain, an antibiotic
resistance marker within SCCmec was needed.

The 450M derivative MR4, which

replaced the mec complex with the gene tetM encoding for tetracycline resistance was
used. The genetic manipulations of deleting the mec region and adding tetM reduced the
size of the SCCmec element from 34.3 kb to 32.0 kb which, theroretically, could be
packaged by bacteriophage 80α. Important for transfer experiments, the type I mec
complex, which has unregulated mecA, had been deleted so that any transfer of SCCmec
type I into a recipient would be enhanced because the cells would not have to adapt to
unregulated mecA expression which is usually a restrictive barrier as noted before (125).
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Figure 9. S. aureus 80α Phage Titers from Select Strains
80α phage lysates were prepared from strains MW2 (SCCmec type IV), COL (SCCmec
type I), 450M (SCCmec type I), and RN4220 as a control and titers were determined by
plating on an indicator strain (RN4220) and calculating the number of PFU/ml. 	
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There were three possible mechanisms considered for phage transfer of SCCmec.
First would be the transfer of the chromosomal copy packaged by phage as a fragment
with flanking homology. Second would be the transfer of the circular element itself.
This would be unlikely unless the element replicated, which is thought not to occur but
has not been formally excluded. Alternatively, SCCmec could recombine with a small,
replicating plasmid if there were areas of homology between SCCmec and the plasmid.
In order to test these hypotheses, high frequency excision of SCCmec in MR4 was driven
as discussed above by overexpression of ccrAB encoded on pWA46. Although the
frequency of inducible excision is not as high as desired it is still a great deal higher than
spontaneous excision and reason enough to use this approach.

While results from

Chapter 3 may suggest that it would be better to induce excision with expression of a type
I ccr gene complex, this type of complex has a deletion in ccrB resulting in a truncated,
non-functional protein, and so inducing with type II ccr gene complex was the best
available approach for driving SCCmec excision in MR4. It was hypothesized that by
driving excision of SCCmec there may be a increased probability of packaging SCCmec
elements within the phage.
After infecting the donor strain with bacteriophage 80α and obtaining a lysate,
PCR was performed to determine what products were present in the encapsidated phage,
and thus potentially able to be transduced (Figure 10). Results indicated that the phage
had packaged a mixed population of integrated, excised, and circular SCCmec. It was
interesting that the presence of the circular SCCmec element was detected. As noted
above, since the circular SCCmec intermediate does not replicate it is unclear how
fragments with this junction were packaged into transducing particles. It is possible that
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Figure 10. 80α virions following MR4 pWA46 infection contain integrated, excised,
and circular SCCmec junctions
Lane A. NEB 1 kb ladder; Lane 1. Left integrated chromosomal junction (primers:
cR2/colA); Lane 2. Right integrated chromosomal junction (primers: colB/cL1); Lane 3.
Excised chromosomal junction (primers: cR2/cL1); Lane 4. Circular SCCmec junction
(primers: colA/colB).
80α was used to prepare a transducing lysate from MR4 pWA46. Phage particles were
purified by PEG precipitation (see Materials and Methods), DNaseI treated to remove
any DNA that was not packaged in the phage capsids, and then subjected to
phenol:chloroform DNA extraction. All four junctions were present demonstrating that a
mixed population of integrated and excised products were encapsidated in the phage,
including the excised circular SCCmec junction.
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circular SCCmec recombined with the small pWA46 plasmid via recombination at ccrAB
and was packaged with pWA46. Using the PCR approach, it is inconclusive how much
of the SCCmec element was present in the phage capsids.
To determine if an intact SCCmec element was present in the phage and able to be
transferred, a transduction experiment was performed using an isogenic recipient strain,
450MEX, which had been passaged to become resistant to rifampin and novobiocin. The
recipient strain also had a plasmid expressing ccrAB from S. aureus MW2, because
previous studies had shown that CcrAB from MW2 favored integration of SCCmec over
excision (71). Thus, any SCCmec transferred via phage into the recipient would likely
be favored to integrate into the chromosome. Important for selection purposes, the donor
strain, MR4 pWA46, was resistant to tetracycline (encoded within SCCmec) and
chloramphenicol (plasmid encoded), and the recipient strain was resistant to rifampin,
novobiocin (chromosomal markers), and chloramphenicol (plasmid encoded). It is
important to note that the donor strain was confirmed to be sensitive to rifampin and
novobiocin while the recipient strain was sensitive to tetracycline. SCCmec transductants
were selected on tetracycline, rifampin, novobiocin, and chloramphenicol.

The

transduction experiment was repeated many times, using bacteriophage 80α, and always
resulted in a single transductant. Thus, the frequency of SCCmec transfer via phage was
very low. The PCR based approach discussed in Chapter 3 was used to confirm transfer
and integration of SCCmec into the chromosome of the recipient (Figure 11). The donor
strain was positive for all four junctions as expected, the recipient strain was only
positive for the excised junction, and the transductant only had chromosomal integrated
junctions. These results confirmed that intact, modified SCCmec type I had transferred
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Figure 11. PCR confirms MR4 SCCmec was mobilized by 80α and integrated into
the recipient chromosome
Lane A. NEB 1 kb ladder; Lane 1. Left integrated chromosomal junction (primers:
cR2/colA); Lane 2. Right integrated chromosomal junction (primers: colB/cL1); Lane 3.
Excised chromosomal junction (primers: cR2/cL1); Lane 4. Circular SCCmec junction
(primers: colA/colB). Donor: MR4 pWA46; Recipient (isogenic): 450MEX pWA43;
Transconjugant: 450MEX::SCCmec pWA43. Donor contained a mixed population of
junctions as expected. Recipient was only positive for the excised chromosomal junction.
The transconjugant was only positive for products indicating SCCmec chromosomal
integration.

	
  

64	
  

via phage 80α into an isogenic recipient and integrated in the host chromosome. A mixed
population of all four junctions is likely not seen in the transductant due to the presence
of plasmid-encoded MW2 type IV ccrAB, which drives integration (71). These results
were obtained at the same time as a report published by Scharn et al. that demonstrated
SCCmec types I and IV could be mobilized into recipient strains by staphylococcal
transducing phages Φ11 and 29 (136).
To determine if SCCmec integrated into the recipient chromosome via att-site
specific recombination mediated by CcrAB or by homologous recombination with the
chromosome, as is typically seen with generalized transduction, two silent single
nucleotide polymorphisms (SNPs) were introduced in the recipient chromosome
upstream of attB to make strain MR10, and the transduction experiment was repeated. If
CcrAB mediated an att-site specific integration in the recipient then the SNPs would be
retained, and if homologous recombination with the chromosome flanking the att site
occurred then the SNPs would be replaced with the donor genotype. The resulting
transductant was sequenced and the SNPs were replaced with the wild-type genotype.
Therefore, transduction of SCCmec type I via phage 80α had occurred by generalized
transduction and homologous recombination in the recipient chromosome and, therefore,
not by CcrAB mediated att-site specific integration.
These results, in addition to similar results published at the same time of these
findings, are not surprising (136). SCCmec types I (34.3 kb) and IV (24.1 kb) are the
smallest of SCCmec elements, and thus would be expected to transduce via the
transducing phages used in these studies. However, this does not explain how the larger
SCCmec elements may be transferred, since they are too large to package into
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transducing particles. In results presented here, the apparent presence of the circular
element in the encapsidated 80α phage particles led to the hypothesis that excised circular
SCCmec element could be packaged and transferred. However, it is assumed that the
circular SCCmec intermediate is non-replicating, and phage 80α is known to package
plasmid DNA from replicating concatemers via the rolling circle mechanism of
replication. Therefore, it is more likely that the circular SCCmec element recombined
with ccrAB on the pWA46 plasmid and was packaged as a single recombinant. It would
be interesting to delete ccrAB from the chromosomal SCCmec element and perform this
experiment again to test this hypothesis and see if there is a loss of circular element in the
encapsidated phage, to gain further knowledge on how the circular element may have
been packaged.
An important consideration, as mentioned previously, is that phages are generally
assumed to be highly species specific with a narrow host range (126, 137). However, the
identical SCCmec element exists in S. epidermidis as in S. aureus. Recent findings
showed that staphylococcal phages were able to transfer SaPI mobile elements across
species (138, 176-179). This is important and potentially widens the host range of phages
previously thought to be restricted.

Therefore, it is possible that the frequency of

SCCmec transfer via phage in the environment is higher than previously believed, and
furthermore it is possible that larger SCCmec elements may be packaged and transferred
via larger phages that have yet to be isolated and characterized.

Transduction

experiments in this chapter confirmed that SCCmec type I is capable of being transferred
via generalized transduction and homologous recombination in the recipient strain, and
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could serve as a potential mechanism for SCCmec transfer in the environment when
conditions are ideal.
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CHAPTER 5
Results:
SCCmec capture on a conjugative plasmid

Because bacterial conjugation has the broadest host range among mechanisms for
horizontal gene transfer it is considered a favorable mechanism for SCCmec transfer and
was therefore tested as well. As mentioned previously, pGO1 was the first Gram-positive
staphylococcal conjugative plasmid subjected to intense genetic analysis to understand its
mechanism of conjugative transfer (155, 165). One specific derivative of pGO1 is the
well-characterized conjugative plasmid pGO400. It is 34 kb and acquired mupirocin
resistance and lost genes encoding resistance to gentamicin, neomycin, and trimethoprim
via recombination at IS elements (164). The finding of multiple pGO1 derivatives with
similar characteristics demonstrates the importance of IS elements because they could
very well serve as a mechanism for the mobility of other staphylococcal resistance genes,
particularly SCCmec.
The conjugative plasmid pGO400 was chosen for conjugation experiments based
on its small size, the presence of three IS431/IS257 elements, and a gene encoding
mupirocin resistance for selection. Since all SCCmec elements contain a copy of IS431
within the mec complex, it was postulated that, following inducible excision of the
SCCmec element, the resulting excised circular element harboring the IS431 element
would recombine with one of the IS431/IS257 elements on pGO400 and be captured for
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mobilization. To maximize excision, as discussed in Chapter 3, the modified N315
SCCmec type II strain MR14 with plasmid pWA46 overexpressing ccrAB and containing
pGO400 was used as the donor.

To select for any potential captured SCCmec on

pGO400, the strain was passaged for nine days in the presence of cadmium and
tetracycline to continually drive ccrAB expression for high frequency excision of the
element and to positively select for cells that had excised SCCmec from the chromosome,
respectively. After nine days, kanamycin was introduced to select for persistence of
SCCmec, and potential captured candidates were selected on chloramphenicol (pWA46
resistance marker), tetracycline (positive selection for excised SCCmec on the
chromosome), mupirocin (pGO400 resistance marker), and kanamycin (SCCmec
resistance marker). The kanamycin selection pressure was increased from the normal 20
µg/ml to 100 µg/ml to avoid any potential break-through kanamycin resistant colonies.
The concentration of kanamycin was tested on a wild-type strain (N315) expressing
kanamycin with the same resistance gene and no growth defects were seen compared to
growth without antibiotic selection. As shown previously in Chapter 3, the SCCmec
circular element is lost over time and thus the kanamycin resistance phenotype would be
lost unless the element was captured on the plasmid replicon. Following the nine days of
passage in the absence of kanamycin, any colonies that grew in the presence of
kanamycin and tetracycline were evaluated as potential candidates for excised
chromosomal SCCmec that had been captured on pGO400. There was an average of
7.5x101 CFU/ml from five replicates that grew with kanamycin, tetracycline, mupirocin,
and chlorampenicol. Based on the total number of cells in the population (8.7x108
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CFU/ml), the apparent capture frequency was 8.6x10-8 (number of candidates/total
population).
To test if SCCmec was truly captured on pGO400 in these candidates, a
conjugative filter mating was performed to see if the suspected recombinant plasmid
could be transferred into a recipient strain. Figure 12 diagrams the initial transfers of
pGO400 with captured SCCmec, and this plasmid is now referred to as pRM27. The first
donor was the potential captured strain, MR14 pWA46 pRM27, and the recipient was
N315EX that was passaged to become resistant to rifampin and novobiocin.
Transconjugants were selected on mupirocin, kanamycin, rifampin, and novobiocin and
confirmed to be sensitive to tetracycline and chloramphenicol (donor resistance
phenotypes). These transconjugants then became the donor for conjugative filter mating
into a new recipient, RN4220 pCN36 (empty vector providing tetracycline resistance
selection), and resulting transconjugants were selected on mupirocin, kanamycin, and
tetracycline and confirmed to be sensitive to rifampin and novobiocin (donor resistance
phenotypes). Figures 13 and 14 show the total number of donors, recipients, and
transconjugants for each transfer. Conjugation frequencies were determined by dividing
the number of transconjugants by the number of donors. From MR14 pWA46 pRM27
into N315EX, the pRM27 conjugation frequency was 9.09x10-8. Then, from N315EX
pRM27 into RN4220 pCN36, the conjugation frequency was 4.08x10-9. In addition,
N315EX pRM27 and RN4220 pCN36 pRM27 were streaked on plates containing
oxacillin and mecA was amplified by PCR to confirm the expression and presence of this
critical gene. Interestingly, mecA expression was a heterotypic, discussed previously, in
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Figure 12. Diagram depicting the first characterized conjugative transfer of
SCCmec
Shown here for simplicity is a flow chart of initial conjugative transfer passages. Each
strain became a donor to the recipient listed immediately below it. These transfer events
were the first to characterize MR14 SCCmec capture on pGO400 and its mobilization
into an isogenic background following by movement into a heterologous host discussed
in figures to follow. Resistant markers are noted that were used for selection. Kan:
kanamycin, Tet: tetracycline, Mup: mupirocin, Chl: chloramphenicol, Rif: rifampin, Nov:
novobiocin. Kan and Mup are markers located on the plasmid pRM27
(pG0400::SCCmec).
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Figure 13. SCCmec transconjugants from conjugative filter mating from a donor to
its isogenic recipient
Conjugative filter matings were performed using equal numbers of donors and recipients.
The donor strain was MR14 pWA46 pRM27 at 2.20x108 CFU/ml and resistant to
kanamycin, tetracycline, chloramphenicol, and mupirocin. The recipient strain was
N315EX at 5.50x108 CFU/ml and resistant to rifampin and novobiocin. The number of
pRM27-containing transconjugants obtained following selection on kanamycin,
mupirocin, rifampin, and novobiocin was 20 CFU/ml. The conjugation frequency was
calculated to be 9.09x10-8 (number transconjugants / number donors).

	
  

72	
  

Figure 14. SCCmec transconjugants from conjugative filter mating from a donor to
a heterologous recipient
Conjugative filter matings were performed using equal numbers of donors and recipients.
The donor strain was N315EX pRM27 at 4.90x109 CFU/ml and resistant to kanamycin,
mupirocin, rifampin, and novobiocin. The recipient strain was RN4220 pCN36 at
4.00x108 CFU/ml and resistant to rifampin and novobiocin. The number of pRM27containing transconjugants obtained following selection on kanamycin, mupirocin, and
tetracycline was 19 CFU/ml. The conjugation frequency was calculated to be 4.08x10-9
(number transconjugants / number donors).

	
  

73	
  

the recipient strains even though the original donor had been passaged to be homotypic.
PFGE was then performed using a restriction enzyme (NarI) that cut pGO400
once and did not cut SCCmec internally, followed by Southern blot analysis using a mecA
probe and a mupirocin probe on the original captured donor, the N315EX RifR NovR
pRM27 transconjugant, the RN4220 pCN36 pRM27 transconjugant, and RN4220
pGO400 as a control (Figure 15). The expected size of empty pGO400 is 34 kb and the
recombinant pGO400 with modified SCCmec type II from MR14 (pRM27) would be 64
kb. In addition, the chromosomal mecA fragment is expected to be 83 kb as predicted in
silico. As shown in Figure 15, a band of approximately 64 kb was seen that hybridized
with both the mecA and the Mupirocin (MUP) probes in the RN4220 pCN36 recipient,
consistent with the capture of SCCmec on pGO400. However, this blot showed two
interesting and unexpected findings. First, in the original donor strain (MR14 pWA46
pRM27), pGO400-captured SCCmec was not detected, as mupirocin and mecA probes
did not co-migrate at 64 kb.

Instead, empty pGO400 vector was present with re-

integrated SCCmec in the chromosome including an extra 16 kb of DNA, increasing the
predicted mecA fragment size from 83 kb in the original donor to 99 kb. The extra 16 kb
of DNA re-integrated into the original host is hypothesized to be a portion of SCCmec
that may carry a promoter driving tetracycline resistance. The use of tetracycline as a
selection marker is thought to have stabilized this single re-insertion event. In the
absence of this selection, multiple insertions may have occurred, as was seen in the
N315EX transconjugant and is described below. Genomic DNA isolated from this strain
has been submitted for whole genome sequencing to determine the nature of the extra 16
kb. It would be interesting to see whether multiple re-insertions would occur in the
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Figure 15. Southern blot confirms SCCmec is captured on conjugative plasmid
pGO400
Strains were digested using a restriction enzyme (NarI) that cut pGO400 once and did not
cut SCCmec internally, separated via PFGE, and followed with Southern blot analysis
using mecA and mupirocin probes. mecA probes for the SCCmec fragment and mupirocin
probes for the conjugative plasmid, pGO400. The expected size of empty pGO400 is 34
kb. SCCmec from MR14 is 30.8 kb. The recombinant pGO400::SCCmec (pRM27)
would be 64 kb. The chromosomal mecA fragment is expected to be 83 kb.
Lane A. MidRangeII PFG Marker (NEB); Lane 1. MR14 pWA46 pRM27; Lane 2.
N315EX pRM27; Lane 3. RN4220 pCN36 pRM27; Lane 4. RN4220 pGO400 (empty
vector control).
Lanes 1 show empty pGO400 with re-integrated SCCmec in the chromosome including
roughly an extra 16 kb of DNA (Table 3). Lanes 2 show empty pGO400 with multiple
insertions of SCCmec (Table 3). Lanes 3 show captured SCCmec element on pGO400
because mecA and MUP probes co-migrate at 64 kb. Lane 4 is a mecA-negative pGO400
control.
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original donor in the absence of tetracycline, as seen with the mecA probe in an isogenic
background in Lane 2 of Figure 15.
The second unexpected result was that re-integration of SCCmec was also seen in
the recipient chromosome of N315EX, which displayed a ladder of multiple sized mecA
bands. The sizes of these bands were determined from a standard curve based on
distance migrated compared to known standard marker migrations (Figure 16) and are
presented in Table 3. Each band was larger than the one below it by approximately 30
kb, the size of the SCCmec element. It was hypothesized that these were multiple
insertion events in a single colony, due to either multiple excision and insertions from the
multicopy plasmid or insertions followed by gene duplications. These were confirmed to
be identical duplicated copies by digesting the DNA from this strain with a restriction
enzyme, SacI, that cuts once within SCCmec, and probing with mecA. As shown in
Figure 17, this resulted in a single band, confirming the presence of multiple duplicated
copies of SCCmec within cells in the population.
It is important to note that the Southern blot analysis may not have been sensitive enough
to detect pRM27 in the original donor and in the N315EX recipient because integration of
SCCmec into the chromosome was favored in this background (discussed below). It is
likely that only a small population of pRM27 remained, while the majority was empty
pGO400 in which SCCmec had recombined out to integrate in the chromosome. This is
supported by that fact that the original donor (MR14 pWA46 pRM27) could be
transferred by conjugative filter mating into N315EX, forming transconjugants that were
then able to serve as new donors into RN4220 pCN36. This indicates that the population
was still present but just not detectable based on the sensitivity of the Southern blot
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Figure 16. Standard curve to determine size of multiple SCCmec re-insertions in
N315EX following conjugative transfer
Standard curve generated by measuring band migration distance (cm) of the MidRange II
PFG Marker fragments plotted against the known size of each band as log (kb). A line
equation was determined and used for extrapolating sizes of fragments seen in samples
based on distance migrated in cm.
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Table 3. The distance migrated in cm for the mecA fragment detected in MR14 pWA46
pRM27 in Lane 1 of Figure 15 and for the multiple mecA bands seen in N315EX pRM27,
Lane 2 of Figure 15. In MR14 pWA46 pRM27 there was determined to be an extra 16
kb of DNA associated with the mecA expected fragment size. In N315EX pRM27, each
band was larger than the one below it by approximately 30 kb, the size of the SCCmec
element.
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Figure 17. Duplicated copies of SCCmec integrated into the N315EX chromosome
following conjugative transfer
MR14 control (Lane 1) and N315EX pRM27 (Lane 2) that had predicted multiple
SCCmec insertions were digested with restriction enzyme SacI which cut once within
SCCmec so that if multiple insertions of SCCmec had occurred the mecA probed
fragments would then co-migrate as one. PFGE was then performed followed by
Southern blot and probing with mecA. This resulted in a collapsed mecA band from the
previous multiple insertions seen in Figure 15. This confirmed the presence of multiple
duplicated copies of SCCmec within cells in the population.
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procedure.
The Southern blot analysis discussed above confirmed SCCmec capture on the
conjugative plasmid in recipient RN4220 pCN36 and reintegration of SCCmec into the
original donor and an isogenic background in N315EX. Following this analysis, a PCR
based approach was also used to characterize SCCmec re-integration in the original
captured donor, MR14 pWA46 pRM27. Figure 18 shows that only the attR SCCmec
chromosomal junction and circular SCCmec junction were amplified in the original
captured donor. The attL SCCmec chromosomal junction did not amplify. This is
hypothesized to be due to the additional 16 kb of DNA that had inserted at this site as
discussed above, which could not be amplified with the PCR conditions used.

In

addition, there was an absence of the excised chromosomal junction, implying that the
cells within the population had all integrated SCCmec. Whole genome sequencing of this
strain will further confirm this.

Also, the circular SCCmec junction was amplified

indicating that if circular SCCmec recombined with pGO400 via IS elements as
hypothesized then the circular junction (attS) would be preserved on the recombinant
conjugative plasmid.
Figure 19 characterizes the N315EX pRM27 transconjugant. This transconjugant
contains the integrated, excised, and circular junctions present as expected. In addition,
controls were included to confirm the amplification products of mupirocin, mecA, and a
N315 specific product while also confirming the absence of a RN4220 specific product
since RN4220 pCN36 was the next recipient.
The same PCR approach was used to characterize the RN4220 pCN36 pRM27
transconjugant. Specifically, results confirm that SCCmec did not integrate into this

	
  

80	
  

Figure 18. PCR analysis to confirm reintegrated SCCmec in MR14 pWA46 pRM27
and preservation of the excised circular SCCmec junction
Lane A. 1 kb ladder (NEB); Lane B. 100 bp (NEB); Lane 1. Left integrated chromosomal
junction (cR1/mR8); Lane 2. Right integrated chromosomal junction (MDR311/cL1);
Lane 3. Excised chromosomal junction (cR1/cL1); Lane 4. Excised circular SCCmec
junction (mR8/MDR311).
MR14 pWA46 pRM27 is the donor passaged for SCCmec capture on pGO400 and MR14
pWA46 pGO400 is the original strain before capture.
The original strain contains all four junctions as expected. The bands are larger than the
usual ~500 bp products for the left integrated chromosomal junction fragment and the
excised chromosomal junction fragment due to the placement of the downstream attL
which results in amplification of the tetM gene also that was inserted into MR14. The
passaged strain shows persistence of the circular excised SCCmec junction because if
circular SCCmec has been captured on pGO400 via IS-mediated recombination then the
presence of the circular junction would be preserved on the recombinant conjugative
plasmid. The negative result for the right integrated chromosomal junction at attL is
likely due to the extra 16 kb associated with the SCCmec element that could not be
amplified under the PCR conditions used. The presence of the right integrated
chromosomal junction at attR is positive for SCCmec integration.
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Figure 19. PCR analysis to characterize the N315EX pRM27 transconjugant
Lane A. 1 kb ladder (NEB); Lane 1. Left integrated chromosomal junction (cR2/mR8);
Lane 2. Right integrated chromosomal junction (MDR311/cL1); Lane 3. Excised
chromosomal junction (cR2/cL1); Lane 4. Excised circular SCCmec junction
(mR8/MDR311); Lane 5. mecA fragment (MDR147/MDR148); Lane 6. ORF0042
fragment specific to RN4220 (8325_0042F/8325_0042R); Lane 7. ermA fragment from
N315
(ermAfwd/ermArev);
Lane
8.
gene
for
mupirocin
resistance
(MupProbeFwd/MupProbeRev); Lane B. 100 bp ladder (NEB).
The transconjugant was positive for all four junctions analyzing SCCmec integration and
excision indicating that the recipient had received SCCmec and it was integrating and
excising from the chromosome as expected. mecA and mupirocin gene products were also
present. Cells were confirmed to be of N315 by amplification of ermA and the absence of
ORF0042 fragment amplification was a control since that was the next recipient (Figure
20). The presence of mecA and mupirocin implied conjugative transfer.
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Figure 20. PCR analysis to characterize the RN4220 pCN36 pRM27 transconjugant
Lane A. 1 kb ladder (NEB); Lane 1. Left integrated chromosomal junction (cR2/mR8);
Lane 2. Right integrated chromosomal junction (MDR311/cL1); Lane 3. Excised
chromosomal junction (cR2/cL1); Lane 4. Excised circular SCCmec junction
(mR8/MDR311); Lane 5. mecA fragment (MDR147/MDR148); Lane 6. ORF0042
fragment specific to RN4220 (8325_0042F/8325_0042R); Lane 7. ermA fragment from
N315
(ermAfwd/ermArev);
Lane
8.
gene
for
mupirocin
resistance
(MupProbeFwd/MupProbeRev); Lane B. 100 bp ladder (NEB).
SCCmec did not integrate into this recipient chromosome (absence of left and right
integrated chromosomal junctions). The only amplified products were the excised
junction, circular SCCmec junction, mecA fragment, RN4220 specific ORF0042
fragment, and the gene for mupirocin resistance. In addition, an N315 specific product
failed to amplify confirming that transconjugants were not donor contaminants. The
presence of mecA and mupirocin implied conjugative transfer.
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recipient chromosome. Instead, Figure 20 shows that the only amplified products were
the excised junction, circular SCCmec junction, mecA, RN4220 specific ORF, and
mupirocin. In addition, an N315 specific product failed to amplify confirming that
transconjugants were not donor contaminants.
When RN4220 pCN36 was the recipient, SCCmec did not integrate into the
chromosome and the captured element remained on the conjugative plasmid under
antibiotic selective pressure.

It has been reported and previously stated that the

sequences surrounding the attB sites vary and can be important for SCCmec CcrABmediated integration (86). Figure 21 compares the attB sites of N315EX and RN4220.
There are three SNPs present within 100 bp upstream of attB core sequence
TATCATAA, and perhaps these may play a role in CcrAB recognition for integration. It
would be interesting to replace the SNPs with those in N315 to see if integration would
be able to occur. However, because there was no integration the captured population was
enriched and these results, again, confirm that the SCCmec element is captured on
pGO400 because the mecA and mupirocin probes co-migrate at 64 kb in comparison to
the control of mupirocin alone at 34 kb. In addition, whole genome sequencing of the
strain RN4220 pCN36 pRM27 confirmed there is no SCCmec integration in the
chromosome and that the SCCmec is captured on the conjugative plasmid via ISmediated recombination in this strain (Figure 22). It would be interesting to see if the
SCCmec element would recombine out from pGO400 and be lost without antibiotic
pressure. That would show that unless incoming SCCmec can integrate into the host
chromosome immediately, the captured recombinant is transient and would thus explain
why SCCmec has never been found on a conjugative plasmid before.
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Figure 21. Alignment of attB DNA regions in RN4220 and N315EX
The alignment was done using ClustalW2 and results show that three SNPs were present
in the 100bp region upstream of attB in the RN4220 site compared to N315. The attB
8bp core is highlighted in blue and the SNPs are highlighted in green.
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Figure 22. Map of pRM27 determined by whole genome sequencing
MR14 SCCmec recombined with pGO400 via IS-mediated recombination.
The assembly was made using the HGAP2 algorithm provided in the PacBio's
SMRTportal package (version 2.3.0) at UNC Pacific Biosciences High Throughput
Sequencing Facility. The image was made using Geneious6 software.
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These results are significant because they demonstrate the first time SCCmec has
been captured on a conjugative plasmid capable of mobilization. The results highlight
the importance of IS elements in plasmid evolution and their ability to serve as a model
for the mobility of resistance elements such as SCCmec among staphylococci.
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CHAPTER 6
Results:
Mobilization of captured SCCmec via conjugation
After the capture of SCCmec on the conjugative plasmid pGO400, it was
important to characterize the mobilization of pRM27 into various heterologous
methicillin-sensitive recipients.

As previously mentioned, staphylococcal conjugative

transfer frequencies are usually in the range of 10-5 to 10-6 per donor cell and can vary
depending on the mating-pair genotypes (126). In addition, the presence of mecA can
serve has a host barrier as discussed before (125). Therefore, it was important to first
determine the baseline conjugative transfer frequencies of empty vector pGO400 into
various recipients. The donor in these conjugation experiments was RN4220 pCN36
pGO400. MSSA recipients as well as methicillin-sensitive S. aureus (MSSE) VCU113
were passaged to become resistant to rifampin and novobiocin.

The endogenous

erythromycin resistant phenotype was used for MSSE VCU129. Donor strains were
confirmed to be sensitive to the antibiotics to which the recipients were resistant. As
mentioned previously, Tn554 (encoding erythromycin resistance) in N315 SCCmec type
II had been deleted in MR14. Table 4 summarizes the methicillin-sensitive recipient
hosts used and their respective pGO400 conjugative transfer frequencies.
conjugative frequencies of empty vector pGO400 ranged from 10-5 to 10-7.
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The

Baseline conjugation frequencies of pGO400
into various recipients

Table 4. Conjugation frequencies of pGO400 ranged from 10-5 to 10-7. Conjugation
frequencies are expressed as the number of transconjugants divided by the number of
donors. Sa = S. aureus; Se = S. epidermidis; CC = clonal complex; NC = not classified.
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Since pGO400 could be transferred into the chosen recipients, the mobilization of
pRM27 into the same recipients was next assessed. The donor strain for these conjugative
filter matings was RN4220 pCN36 pRM27 since Southern blot and PCR analyses
confirmed that the SCCmec population was solely on the captured conjugative plasmid.
This would increase the chance of mobilization because there was no competition for
SCCmec re-integrating in the chromosome of the donor and thus decreasing the
population of captured replicons. Table 5 summarizes the conjugation frequencies of
pRM27 into each recipient. These data show a striking difference to the results obtained
with pGO400, with transconjugants obtained at a much lower frequency or in some cases
not at all. In addition, when incubated on agar plates containing oxacillin, each recipient
grew - indicating the presence of mecA - but all were heterotypic for oxacillin resistance.
One very important result was the ability of pRM27 to mate into a S. epidermidis
strain (VCU129). Confirmation that the recipient was indeed S. epidermidis was done by
plating donor, recipient, and transconjugant on phenol red mannitol salt agar (Figure 23)
and also by performing PCR analysis for mecA and a S. epidermidis specific marker,
arcC (Figure 24). The high salt concentraion in this medium selects for staphylococci,
and if a species can utilize mannitol as a carbon source then an acidic byproduct is
formed that will change the pH of the medium and cause the phenol red in the agar to
turn yellow. S. aureus can utilize mannitol and therefore growth of the donor causes the
agar to turn yellow as expected. S. epidermidis cannot utilize mannitol, and the recipient
and transconjuants grown on this agar did not result in a color change, confirming that
they were S. epidermidis. PCR results confirmed that mecA was detected in the donor
and transconjugant but not in the recipient before mating, and the donor was negative for
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Conjugation frequencies of pRM27
into various recipients

Table 5. Conjugation frequencies of pRM27, when detected, ranged from 10-7 to 10-10.
Conjugation frequencies are expressed as the number of transconjugants divided by the
number of donors. Sa = S. aureus; Se = S. epidermidis; CC = clonal complex; NC = not
classified
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Figure 23. Confirmation that the VCU129 recipient of pRM27 is S. epidermidis by
plating on phenol red mannitol salt agar
Confirmation that the recipient was indeed S. epidermidis was done by plating donor,
recipient, and transconjugant on phenol red mannitol salt agar. Plates are initially red
without bacterial growth. The high salt concentraion in this medium selects for
staphylococci, and if a species can utilize mannitol as a carbon source then an acidic
byproduct is formed that will change the pH of the medium and cause the phenol red in
the agar to turn yellow. S. aureus can utilize mannitol and growth of the donor causes the
agar to turn yellow. S. epidermidis cannot utilize mannitol, and the recipient and
transconjuants grown on this agar did not result in a color change confirming they were S.
epidermidis.
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Figure 24. PCR analysis to confirm S. epidermidis pRM27 transconjugants
Six S. epidermidis transconjugants were confirmed by PCR analysis.
Lane A. 1 kb ladder (NEB); Lanes 1-6. S. epidermidis transconjugants; Lane 7. RN4220
pCN36 pRM27 donor control; Lane 8. S. epidermidis VCU129 recipient control.
The left panel is PCR performed using mecA primers specfic to the donor alone and
confirming that S. epidermidis transconjugants had aquired mecA because the S.
epidermidis VCU129 recipient is negative for mecA prior to mating.
The right panel is PCR performed using arcC S. epidermidis specific primers. All
transconjugants were confirmed to be S. epidermidis as the tested positive for the
presence of arcC. The donor RN4220 pCN36 pRM27 was negative for arcC and the
recipient S. epidermidis VCU129 was positive for arcC as expected.
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a S. epidermidis specific gene product while the recipient and transconjugants were
positive. These results confirm a mechanism of cross-species transfer of SCCmec that is
known to have happened from epidemiological dataa but never been shown in the
laboratory. Equally important, VCU129 pRM27 was able to mate pRM27 back into S.
aureus. Plasmid pRM27 from VCU129 mated into RN4220 RifR NovR at a conjugation
frequency of 1.96x10-6 and into MR14EX RifR NovR at a conjugation frequency of
2.86x10-7. This is significant because it is believed that CoNS species may be the origin
of SCCmec, as discussed previously (34, 111).

It would be interesting to test for

integration in each recipient discussed above as well as to compare more attB sites and
test other MSSA/MSSE strains as potential recipients, to further classify the ability and
restrictions of SCCmec mobilization and chromosomal integration.
Results shown here and in Chapter 5 demonstrate that SCCmec can be captured
on a conjugative plasmid and can be transferred consecutively into various heterologous
S. aureus hosts as well as into S. epidermidis and back into S. aureus. This shows for the
first time that conjugative transfer is a probable mechanism of SCCmec transfer in nature.
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CHAPTER 7
Discussion

SCCmec elements are designated as genomic islands.

Genomic islands are

mobile DNA elements that are able to undergo horizontal gene transfer (HGT) by
excision, transfer, and integration into a new cell. Horizontal transfer of SCCmec into
different S. aureus lineages has played a significant role in the evolution of MRSA.
However, a well-characterized mechanism by which SCCmec moves among different
strains and species of staphylococci has never been demonstrated until now.
Horizontal gene transfer can occur via transformation, transduction, and/or
conjugation. One obvious potential means for horizontal transfer of SCCmec is via
generalized transduction. This study shows that phage 80α transduces SCCmec type I
into a recipient, followed by SCCmec integration into the chromosome via homologous
recombination.

SCCmec type I is 34.3 kb in size and is well within the range of

chromosomal fragments that can be packaged by bacteriophage 80α which has a genome
size of 43.9 kb. Based on these findings and other published work discussed previously,
MRSA strains that carry smaller SCCmec types (types I and IV) are more likely to be
packaged and transferred by the known staphylococcal transducing phages that have a
genome size around 40 kb. This transduction mechanism, however, does not explain how
the larger SCCmec elements may be transduced followed by att site-specific integration.
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It is, however, possible that larger SCCmec elements can be packaged and
transferred via other staphylococcal phages. S. aureus phage genomes range in size from
less than 20 kb to 140 kb (167, 168). The largest characterized S. aureus phages belong
to the Twort-like family, but they do not transduce foreign DNA and are, thus, not
considered as a possible vehicle for SCCmec transfer (169).

Another potential

mechanism for SCCmec transfer involves the induction of S. aureus prophages. All S.
aureus genomes sequenced to date contain at least one prophage, and many strains carry
up to four (168). Prophage induction and HGT have been extensively studied and are
important mechanisms for transfer of staphylococcal virulence genes.

Specifically,

prophage induction can be triggered by antibiotics and oxygen radicals (170). Also, there
have been many findings of bacteriophage transfer between S. aureus isolates during
colonization and infection (171-174). Therefore, it is possible that SCCmec could be
packaged and transferred following prophage induction and, thus, could likely explain a
mechanism of the spread of SCCmec among MRSA clinical isolates during infection.
Based on sequence analysis, most of the S. aureus prophages are around 40 kb in size, so
transfer of all SCCmec elements this way would be limited. Recently, however, a large
127.2 kb staphylococcal prophage was discovered in S. aureus strain TW20 that can
transfer to few S. aureus strains (175).

As discussed previously, this prophage is

extremely rare as it is only found in a few S. aureus isolates and, therefore, cannot
explain an overall mechanism for SCCmec transfer among different lineages and across
species. However, this finding highlights the possibility that larger SCCmec elements
may be packaged and transferred via phages that have yet to be isolated and
characterized.

	
  

96	
  

Another important characteristic when considering transduction as a means for
SCCmec transfer among lineages and species is phage host range.

As discussed

previously, staphylococcal phages have been shown to participate in interspecies HGT
(138, 176-179). In addition, the host range of staphylococcal phages is much wider than
previously believed, if just the ability to adsorb and inject DNA is considered. Therefore,
it is possible that the frequency of SCCmec transfer via phage in nature is higher than
what was observed under laboratory conditions presented in this work.
The generalized transduction of SCCmec observed in this study involved
subsequent SCCmec integration via homologous recombination in an ideal recipient
background. Importantly, all MRSA strains sequenced to date show SCCmec integrated
site-specifically via an att site within orfX, and S. aureus strains vary in the region
downstream of orfX. Therefore, homologous recombination alone cannot explain the
acquisition of SCCmec in different lineages and among other species. As mentioned
previously, what is interesting in these studies is that the excised circular SCCmec
junction had been packaged by the phage. This is intriguing because upon transfer of the
circular element integration could then occur via the specific att sites and, thus, warrants
further investigation as previously described. In addition, based on the findings by
Maiques et al. with SaPIbov2 transfer, it is possible that linear SCCmec chromosomal
fragments could be transduced into a recipient followed by ccrAB-mediated excision,
circularization, and integration into the attB site of the recipient (177). Because SCCmec
excision was induced in the donor strain preceding transduction in this work, there would
be fewer integrated chromosomal SCCmec elements within the population. It would be
interesting to perform transduction experiments without inducing SCCmec excision in
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order to increase the transducing frequency of linear chromosomal fragments and then
test if any transductants had acquired SCCmec via att site-specific integration in this
regard. However, this mechanism would not explain subsequent mobility and att sitespecific integration of SCCmec as many elements have truncations or deletions within
their ccr complexes making the recombinases nonfunctional. Therefore, perhaps in some
instances regarding certain SCCmec types and specific lineages, generalized transduction
followed by homologous recombination in the recipient is a likely means for SCCmec
transfer among S. aureus strains in nature.
Conjugation is a highly attractive alternative for transfer of SCCmec.
Staphylococcal conjugative plasmids have a broad host range and can transfer among
staphylococci via a mechanism similar to the ubiquitous Gram-negative conjugative
plasmids (143-145). As discussed previously, the existence of multiple staphylococcal
conjugative plasmid derivatives showed that segments of DNA containing either entire
integrated plasmids or antimicrobial resistance genes could be acquired via IS-mediated
recombination (152, 159, 164). This IS-mediated capture suggests a potential mechanism
for the mobility of any genomic island containing a homologous IS element.

The

sequencing of numerous bacterial strains has revealed a huge diversity of genomic
islands, suggesting that any which contain an IS element could be captured on a
conjugative plasmid this way. Specifically, because all SCCmec elements contain an
IS431 element, this mechanism seems highly favorable for SCCmec transfer.
Indeed, these studies show, for the first time, the capture of a circular 30.8 kb
SCCmec element on the conjugative plasmid pGO400.

Following capture of the

SCCmec element on the conjugative plasmid transfer to both MSSA and MSSE recipients
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was confirmed. As mentioned previously, it is believed that S. aureus acquired SCCmec
from coagulase-negative staphylococci. Therefore, these studies are extremely important
because, as never before been demonstrated, they define a mechanism of SCCmec
transfer between S. aureus and S. epidermidis that likely represents transmission in the
environment.
Upon transfer into the MSSA recipients, data show integration of SCCmec in an
isogenic recipient chromosome (N315EX) while no integration was detected in the
heterologous recipient (RN4220 pCN36). In addition to the expected integration into the
chromosome of an isogenic recipient, it was observed that SCCmec had integrated as
concatemers. These multiple tandem copies of SCCmec highlight the importance of
multiple integrations at the attL site that is characteristic of clinical isolates discussed
previously, and may also explain the rearrangements seen in novel SCCmec types. On
the other hand, integration was not seen in the recipient RN4220.

As mentioned,

comparison of the attB sites in N315EX and RN4220 by sequence alignment confirmed
the presence of three SNPs 100bp upstream of attB. Previous studies have shown this
region to be important for CcrAB recognition and site-specific integration of SCCmec
(86). The difference in upstream sequence may account for failure of the SCCmec to
integrate in RN4220. This result may explain why certain lineages of S. aureus have not
acquired SCCmec, and could lead to potential new avenues of investigation about the role
of site-specific recognition sequences in SCCmec integration by CcrAB.
Overall, it is suggested that SCCmec elements have been independently acquired
several times through HGT, and transduction and conjugation are described as
mechanisms of SCCmec transfer in this work. Transduction results were only able to
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show SCCmec transfer via generalized transduction followed by homologous
recombination, and thus the results obtained under laboratory conditions are limited for
describing a detailed mechanism of SCCmec transfer. However, given the importance
and variation of transduction in S. aureus HGT, other transduction mechanisms discussed
above warrant further investigation, and it is believed that transduction of SCCmec
occurs in nature under ideal conditions.

The data from conjugation experiments,

however, characterize a specific, detailed mechanism of SCCmec transfer that is likely to
occur readily in nature. Importantly, SCCmec can be captured on a conjugative plasmid
via IS-mediated recombination that can then be transferred into S. epidermidis followed
by subsequent transfer back into S. aureus.

This strengthens the argument for

conjugation as an important mechanism for SCCmec transfer. The demonstration of
cross-species transfer offers an explanation to previous data suggesting that coagulasenegative staphylococci serve as the reservoir of SCCmec for S. aureus. Therefore, these
data describe, for the first time, a detailed mechanism for the environmental
dissemination of methicillin resistance in nature. This knowledge can provide important
insight into SCCmec HGT as well as a means for understanding the emergence and
persistence of SCCmec in both present and future MRSA isolates.
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“The most beautiful experience we can have is the mysterious.”
― Albert Einstein
“Somewhere, something incredible is waiting to be known.”
― Carl Sagan
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